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ABSTRACT

Listeria monocytogenes is a psychrotrophic, gram-positive pathogen frequently
involved in outbreaks of food-borne disease in which milk, cheese, meat, and vegetables
represent the incriminated foodstuffs. L. monocytogenes biofilms formed on food contact
surfaces and processing environments are the major sources of contamination to ready-toeat food products. Nanotechnology as an emerging new technology has many biological
applications. The objectives of this study were to apply immunonanoparticles, carboxyl
modified nanoparticles covalently bound with anti-L. monocytogenes, for L.
monocytogenes detection and inactivation.
Immunonanopaticles and fluorescent immunonanoparticles were applied to indirect
fluorescent immunoassay and direct fluorescent immunoassay, respectively, for sensitive
detection of L. monocytogenes in biofilms. Immunonaoparticle-based immunoassay
generated fluorescent intensity 16 times higher than antibody-based traditional
immunoassay. In two-species biofilms, L. monocytogenes cells at different depths (0-3
µm) of biofilms were successfully detected by both immunonanoparticle-based indirect
immunoassay and fluorescent immunonanoparticle-based direct immunoassay.
Immuno-magnetic-nanoparticle (IMNP)-based immunomagnetic separation (IMS)
in combination with real-time PCR (RT-PCR) was used for a rapid and quantitative
detection of L. monocytogenes in artificially contaminated milk. Capture efficiencies
(CEs) by plating for IMNP-based IMS were 1.4~26 times higher than those of
Dynabeads®-based IMS. When combined with RT-PCR, IMNP-based method, with a
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detection limit of 226 CFU/0.5 ml milk, was ca. 3 log magnitude more sensitive than
Dynabeads®-based method. Cell numbers derived from IMNP-based RT-PCR were more
than 25 times closer to the actual cell numbers present in milk samples than those from
Dynabeads® based RT-PCR.
The antimicrobial activity of lysozyme-carrying immunonanoparticles against L.
monocytogenes was studied. Enhanced antibacterial activity of lysozyme-carrying
immunonanoparticles was achieved when anti-L. monocytogenes at the concentration of
0.04 µg/ml was used for coating nanoparticles and the resulting immunonanoparticles
were coated with lysozyme for 6 h. Lysozyme-carrying immunonanoparticles (37 µg
lysozyme/ml) exerted significantly (P < 0.05) higher anti-L. monocytogenes activities
than lysozyme-carrying nanoparticles (37 µg lysozyme/ml), lysozyme solutions at higher
concentrations (50 and 500 µg/ml).
In conclusion, our results demonstrated that nanotechnology could significantly
improve the current pathogen detection methods and enhance the antimicrobial activities
of existing inactivation methods.
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CHAPTER ONE
LITERATURE REVIEW

Listeria monocytogenes and listeriosis
The genus Listeria is Gram-positive, facultative anaerobic, non-sporing rods 0.5 µm
in widthe and 0.5-2.0 µm in length. They are catalase-positive, oxidase-negative and
motile at 20-25°C but non-motile at 37°C (Seeliger and Jones 1986). The genus Listeria
currently is devided into six species: Listeria monocytogenes, Listeria ivanovii, Listeria
welshimeri, Listeria innocua, Listeria seeligeri and Listeria grayi (Vazquez-Boland et al.
2001). Only L. monocytogenes and L. ivanovii are generally considered to be pathogenic.
L. monocytogenes causes disease in humans and animals, and L. ivanovii in animals
(Vazquez-Boland et al. 2001).
L. monocytogenes most often affects those people with severe underlying conditions
(such as immunosuppressive therapy, AIDS, and chronic conditions such as cirrhosis that
impair the immune system), pregnant women, unborn or newly delivered infants, and the
elderly (McLauchlin et al., 2003). Most listeriosis cases are associated with serotypes: 4b
(37–64%); 1/2a (15–25%) and 1/2b (10–35%) (Farber and Peterkin 1991).
Listeriosis can be grouped into two categories: invasive and non-invasive listeriosis.
In the case of invasive listeriosis, following invasion of the intestinal tissue, L.
monocytogenes are very easy to spread to blood, liver, the pregnant uterus or the central
nervous system (McLauchlin et al., 2003). Manifestations of invasive listeriosis include,
but are not limited to, bacteraemia, central nervous system infections (meningitis,
encephalitis, meningoencephalitis), prodromal illness in pregnant women, miscarriage,
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premature birth, stillbirth, and neonatal disease (McLauchlin et al., 2003). Invasive
listerioses can be life threatening, with fatality rates of 20 to 30% (Mead et al., 1999).
Non-invasive listeriosis, referred to as febrile listerial gastroenteritis, has symptoms of
gastroenteritis, such as diarrhoea, fever, headache and myalgia, after a short period of
incubation (Aureli et al., 2000).
The significance of foods as the primary route of transmission of L. monocytogenes
was recognized after several large, common-source outbreaks of listeriosis occurred in
North America and Europe during the 1980s (Broome et al. 1990). Due to the severity of
the disease and the very frequent involvement of processed foods, especially during
outbreaks, the social and economic impact of listeriosis is among the highest of the
foodborne diseases (Roberts and Pinner, 1990). An important factor in foodborne
listeriosis is that the pathogen can grow in a wide temperature range, from -1.5 to 45ºC,
and pH range, from 4.3 to 9.6 (Seeliger and Jones 1986; Hudson et al. 1994).
L. monocytogenes is widely distributed in the environment and has been isolated
from a variety of sources including soil, vegetation, silage, faecal material, sewage and
water. L. monocytogenes is frequently present in raw foods of both plant and animal
origin. It is also present in cooked foods due to post-processing contamination, a long
recommended refrigerated shelf-life or insufficient heat treatment. L. monocytogenes has
been isolated from foods such as raw and pasteurized fluid milk, cheeses (particularly
soft-ripened varieties), ice cream, raw vegetables, fermented raw-meat and cooked
sausages, raw and cooked poultry, raw meats, and raw and smoked seafood (McLauchlin
et al., 2003). Sometimes this bacterium is also found on fresh fruits and vegetables
(Berrada et al. 2006).
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Rapid detection of L. monocytogenes in food samples
The conventional microbiological methods for the detection of L. monocytogenes
are based on three basic steps: one- or two-step selective enrichment, L. monocytogenes
isolation on selective media and biochemical confirmation. Currently, the culture-based
methods are primary official methods for the detection of L. monocytogenes in food
samples, e.g. meat and poultry products as required by the US Department of
Agriculture–Food Safety and Inspection Service (USDA–FSIS) (Silbernagel et al., 2004;
Wallace et al., 2003), dairy (Kells and Gilmour, 2004), fruit, vegetable and seafood
products (Norton et al., 2001; Thimothe et al., 2004) by Federal Drug Administration
(FDA), and all foods by Netherlands Government Food Inspection Service (NGFIS)
(Donnelly, 2001). Unfortunately, these culturing methods depending on different
selective medium are generally time consuming and labor intensive, usually requiring 3–
7 days for a presumptive result.
Given the severity of L. monocytogenes infections and its ability to grow at
refrigeration temperatures, FDA has adopted a ‘zero-tolerance’ policy for the presence in
food (Donnelly, 2001). In Canada, the limit is 100 CFU/g in ready-to-eat foods (Health
Canada, 2004). In order to avoid the large costs and legal repercussions involved in a
recall of food products, food producers must be able to detect low levels of L.
monocytogenes quickly and accurately. The critical issue facing the implementation of
any "zero-tolerance" policy relates to the lack of rapid and reliable procedures for the
detection of low numbers of Listeria in foods. As a result, over the past several years, a
variety of rapid methods has been investigated for detecting Listeria, such as typical or
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derived immunological assays, nucleic acid–based tests, and physicochemical tests based
on growth of microorganism.

Molecular biological detection methods
Identification of L. monocytogenes using nucleic acid-based methods is becoming
increasingly popular because these techniques are extremely accurate, sensitive and
specific.

Polymerase chain reaction (PCR)
PCR is a technique to amplify small amounts or even a single copy of target DNA
using a heat stable DNA polymerase and two primers. The presence of L. monocytogenes,
both live and dead, can be detected by simply determining if a specific pathogen gene of
interest is present. PCR differentiate L. monocytogenes from other Listeria species by
exploiting moleculare differences in 16S and 23 S rRNA (Call et al., 2003; Schmid et al.,
2003), the hlyA gene (encoding listeriolysin O) (Nogva et al., 2000; Hudson et al., 2001),
the iap gene (encoding an invasion-associated protein) (Cocolin et al., 2002; Schmid et
al., 2003), the inl (encoding internalin) gene (Jung et al., 2003; Lunge et al., 2002) and
other genes. Among these genes, the most commonly used one has been hlyA
(Rodrıíguez-Laázaro et al., 2004a). Performing PCR dramatically reduces testing time,
reagents and labor costs are all reduced. The technique is conducive to automation and
high throughput processing using 96-well plates.
Numerous PCR studies have been conducted for detecting L. monocytogenes in
dairy and meat products (Fluit et al., 1993; Herman et al., 1995; Hudson et al., 2001;
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Amagliani et al., 2004). However, application of PCR to the direct detection of pathogens
present in foods has been limited by the complex composition of food components, which
contain PCR inhibitors (Abu Al-Soud and Radstrom 1998). In most cases,
immunomagnetic separation (IMS) was applied to purify and concentrate target DNA
from reaction-inhibiting food matrices prior to PCR (Fluit et al., 1993; Herman et al.,
1995; Hudson et al., 2001; Amagliani et al., 2004).
One of the commercially available PCR tests is the BAX® PCR system (Qualicon,
Wilmington, DE, USA), which has been recommended in the United States as Official
First Action for detection of L. monocytogenes (Silbernagel et al., 2004). This method
has been tested in the field on a variety of different sample types including dairy
products, fruits and vegetables (except radishes), seafoods, raw and processed meats and
poultry. BAX system performed as well as or even better than those standard reference
methods in detecting L. monocytogenes from food samples.

Real-time PCR
Traditional PCR methods are able to detect the presence of the pathogen, but are not
able to quantify the level of pathogen contamination. Establishing the actual number of
contaminating L. monocytogenes cells in food and environmental samples is an important
factor when investigating outbreaks of listeriosis. One way to approach this problem is
the use of real-time PCR. Real-time PCR can be quantitative since the resulting
fluorescence of incorporated fluorescent marker is proportional to the number of
pathogens present in original sample. Real-time PCR eliminates the need to run agarose
gels for PCR product detection.
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Nogva et al. (2000) developed a real-time PCR method for quantification of L.
monocytogenes in water, skimmed and raw milk. The detection limit was approximately
6 to 60 CFU per reaction and quantification was linear over at least 7 log units. The
method could be completed within 3 h. In combination of filtration, real-time PCR was
able to detect as few as 100 CFU of L. monocytogenes per gram of meat products and the
quantification limit was 1,000 CFU/g (Rodrıíguez-Laázaro et al., 2004b). Real-time PCR
was also able to simultaneously detect L. monocytogenes, Salmonella Typhimurium, and
E. coli O157:H7 from produce (Bhagwat 2003). It achieved the detection limits of 1
cell/ml for E. coli O157:H7 and Salmonella spp. and 102–103 cells/ ml for L.
monocytogenes after enrichment.

Reverse transcription-PCR
To address the need of detecting only living pathogenic cells, bacterial RNA could
be applied rather than DNA. Message RNA is a labile molecule and readily degraded
after cell death by RNases and environmental factors such as heat, whereas the DNA can
last for years, depending on storage conditions. Reverse transcription-PCR use a reverse
transcriptase to translate mRNA into complementary DNA (cDNA). The cDNA is then
used as template and amplified under normal PCR conditions.
Klein and Juneja (1997) used reverse transcription-PCR to detect live L.
monocytogenes in both pure culture and artificially contaminated cooked ground beef by
targeting mRNA transcripts of the iap (encoding the invasion associated surface protein
p60), hlyA (encoding the hemolysin listeriolysin O) and prfA (encoding the main
virulence gene regulator) genes. Using the iap gene as the target, the researchers were
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able to detect L. monocytogenes at a concentration of 10–15 cells/ml in pure culture and 3
CFU/g of inoculated meat after 2 h of culture enrichment. Using this method, L.
monocytogenes has also been detected in waste samples by targeting the transcripts for
rRNA genes (Burtscher et al., 2003).

Nucleic acid sequence-based amplification (NASBA)
NASBA is an alternative to conventional PCR for eliminating thermal cycles. It is
based on the action of three enzymes: 1) a reverse transcriptase which is used to produce
a cDNA-RNA hybrid; 2) an RNase enzyme which removes the RNA from the hybrid
molecule to synthesise a double stranded cDNA molecule; and 3) T7 polymerase used for
the generation of RNA transcripts by using cDNA as a template (Gasanov et al., 2005).
Single stranded RNA moleules yielded from NASBA can be detected either by
conventional agarose electrophoresis or by hybridization assays. Aside from ensuring
detection of only viable cells, NASBA removes the need for a costly thermocycler. By
targeting the 16S rRNA and also the mRNA of hlyA, NASBA has been applied to detect
viable L. monocytogenes at 10 CFU/60 g meat or seafood products (Uyttendaele et al.,
1995; Blais et al., 1997).

Nucleic acid hybridization
In contrast to PCR, comparatively large amounts of target DNA or RNA are
required to perform hybridization. The presence of L. monocytogenes is detected using a
fluorescently labeled oligonucleotide probe complementary to the target nucleic acid
sequence. Wagner et al. (1998) developed an iap-mRNA-based in situ identification
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protocol for L. monocytogenes. It was the first time that successful identification of
mRNA from a virulence factor in bacteria has been demonstrated. Vermicon
identification technology (VIT®, Munich, Germany), a rapid commercial test system, has
become available for the identification of L. monocytogenes recently (Stephan et al.,
2003). Based on fluorescently labeled probes to intracellular target RNA, this method has
been used for the identification of L. monocytogenes in sewage and sludge samples.

DNA microarray
DNA microarray is an exiting new technology, which is based on DNA or RNA
hybridization. Microarrays are composed of a number of discreetly located DNA probes
fixed on a solid support matrix. There are two main microarray formats, one is based on
sequence specific oligonucleotides and the other employs specific PCR products. For
PCR-based microarrys, target DNA is labeled with a fluorochrome such as Cy3 or Cy5
prior to DNA hybridization. DNA fragments with complementary sequences will bind to
immobilized PCR products and are visualized via the label. Oligonucleotide-based
microarrays offer significant advantages over PCR-based microarrays. Use of synthetic
oligonucleotides eliminates the need for RT-PCR amplification and product purification
steps, and hybridization can be performed directly using total bacterial RNA, which is
labeled prior to hybridization.
Volokhov et al., (2002) used multiple primer sets to amplify six virulence factor
genes (iap, hly, inlB, plcA, plcB, and clpE) of Listeria. Fluorescently synthesized singlestranded DNA was hybridized to the multiple individual oligonucleotide probes specific
for each Listeria species and immobilized on a glass surface. They demonstrated that this
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method allowed simultaneous detection and discrimination of six Listeria species based
on the iap genes. Borucki et al. (2003) developed a mixed genome microarray to identify
gene sequences that differentiate among serotypes (1/2a and 1/2c vs. 1/2b and 4b) of L.
monocytogenes. Sergeev et al. (2004) developed a microarray that was capable of
detecting six Listeria species and the detection limit is 200 CFU L. monocytogenes per
reaction in pure culture. The most attractive feature of this new technology is the
capability of simultaneous identification of Listeria strains and serotypes at once.
However, the disadvantages are that high amounts of target DNA or RNA are required to
perform the test and high-throughput testing is cost prohibitive.

Immunoassays for pathogen detection
Immunoassays are based on the specific binding antibodies to corresponding
antigens. Antigens can be proteins, polysaccharides or any type of molecule on the cell
surface. Immunoassays have been applied in food testing because of their simplicity and
relative inexpensive. Food samples can be analyzed directly by immunoassays without
tedious sample preparation.
The problem with immunoassays is that most of the antibodies used to date have
been only genus specific rather than species specific for Listeria (Palumbo et al. 2003).
From a foodborne pathogen-detection perspective, this is important since of the six
known Listeria species, only L. monocytogenes is pathogenic to humans. A single-chain
antibody fragment (scFv) was one of the few examples of an antibody that is L.
monocytogenes specific (Paoli et al., 2004). However, the affinity of the scFv needs to be
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improved although preliminary analysis indicates the affinity is sufficient for applications
in isolation and detection of L. monocytogenes.

Enzyme linked immunosorbent assay (ELISA)
ELISAs are the most common format used for immunodetection of pathogens,
including direct ELISAs, sandwich ELISAs and competitive ELISAs. Many of these
ELISA methods are available as commercial kits and are approved by regulatory
agencies. Most assays have comparable results to the FDA and USDA–FSIS culturebased methods for pathogen detection. The detection limits for pathogens were between
103 and 105 CFU/ml and the enrichment was involved to provide sufficient numbers of
bacterial cells for ELISA (de Boer and Beumer, 1999).
Two commercial kits such as the TECRA Listeria Visual Immunoassay (TLVIA,
TECRA International) and the Assurance Listeria EIA (BioControl Systems, Inc) were
based on polyclonal antibody-based sandwich ELISA. Agreement of TLVIA with USDA
culture-based method was 94.7% (Knight et al., 1996), while agreement for the
Assurance assay was 81% (Feldstine et al., 1997). Both assays are Listeria sp. specific
rather than L. monocytogenes specific.

Fluorescent immunoassays
The colorimetric reaction as the final step of signal amplification for ELISA could
be eliminated by conjugating fluorescent labels to the antibodies. However, the use of
fluorescent labels increases the cost of the immunoassay. Fluorescent immunoassay
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includes enzyme-linked fluorescent immunoassay, direct fluorescent immunoassay and
indirect fluorescent immunoassay.
Sewell et al. (2003) demonstrated that VIDAS (bioMérieux Vitek), a commercial
system, can identify Listeria to the genus or species (L. monocytogenes) level using
monoclonal antibody conjugated to a fluorescent reporter dye. Culture enrichment was
used to increase cell concentration to the detection limit of 104–105 CFU/ml by this
method. VIDAS method was as good as or better than those traditional culture basedmethods when food products such as fish, cooked roast beef, ice cream, brie cheese, and
green beans were evaluated (Gargar et al., 2005; Silbernagel et al. 2005).
Fluorescent immunoassay allowed simultaneous detection of foodborne pathogens
like E. coli O157:H7, S. Typhimurium, C. jejuni, and L. monocytogenes (Dunbar et al.,
2003). In the immunoassays, fluorescence was bacteria concentration dependent with a
detection limit of equal to or less than 1000 organisms/ml.

Immunosensor
The antibody–antigen interaction causes changes in mass at the surface and thus
results a change in resonant wavelength or angle measurable by surface plasmon
resonance (SPR). Biosensors based on SPR allow rapid and "real-time" identification of
pathogens. Leonard et al. (2004) mixed polyclonal rabbit anti-whole L. monocytogenes
cell antibody with various concentrations of L. monocytogenes cells. The unbound
antibody was detected using a polyclonal goat anti-rabbit Fab antibody immobilized on
the chip of SPR sensor. The larger the number of L. monocytogenes cells in the sample,
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the fewer the unbound antibodies were available to bind the coated chip. This method
allowed the detection of 105 L. monocytogenes cells/ml in less than 30 min.
Fiber-optic biosensors exploit the measurement of fluorescent light excited by an
evanescent wave generated by a laser to quantitatively detect biomolecules immobilized
on the fiber surface (Geng et al., 2004). Fiber-optic biosensors based on a sandwich
immunoassay have been exploited to detect L. monocytogenes cells. In the assay a
capture antibody was immobilized onto the optical fibers, and a fluorescent dye-labeled
antibody was used for detection. The measurement of fluorescent light enables
quantitative detection of biomolecules immobilized on the fiber surface. Tims et al.
(2001) reported a detection limit of 4.1 ×108 CFU/ml of L. monocytogenes by using this
assay.

They concluded that the quality of antibodies is a key facter in improving

sensitivity. Geng et al. (2004) improved the sensitivity of the fiber-optic biosensor to 4.3
×103 CFU/ml of L. monocytogenes cells by developing capture and detection antibody
with higher quality and specificity.

Immunomagnetic separation
In order to detect pathogens in low numbers from food samples, the populations of
pathogens should reach a detectable level of whatever detection method being chosen.
This holds true whether the detection method is culture, molecular, or immunoassay
based. Enrichment is one of the strategies being used to selectively increase the numbers
of pathogens. However, the enrichment steps which generally take between 24 and 72 h
to complete still cause delay in the overall detection time.
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Immunomagnetic separation (IMS) has been widely used last decade in an attempt
to reduce the detection time and improve detection sensitivity. Magnetic particles
conjugated with specific antibody can selectively separate target pathogen out of food
matrix. The specificity of IMS depends on the antibody used. Commercially available
anti-Listeria Dynabeads® (Dynal Inc.) have affinity for all Listeria species. The
application of microbeads (3.8 µm in diameter) coated anti-Listeria genus-specific
antibody facilitated a reduction in the time of Listeria detection in cheese by two days
without affecting the sensitivity (Kaclíková et al., 2001).
IMS as a sample preparation method is always in combination with other rapid
methods for detection of L. monocytogenes. Hudson et al. (2001) used immunomagnetic
separation to isolate L. monocytogenes directly from ham. IMS in combination with PCR
allowed detection of as few as 1–2 L. monocytogenes cells per gram of ham sample after
enrichment (Hudson et al. 2001). Although IMS reduced detection time to about 1 day,
its efficiency needed further improvement since only about 20% of cells were recovered.
Using a two-step method, IMS in combination with cytotoxicity assay, viable L.
monocytogenes could be isolated, detected, and confirmed as cytopathogenic within 28 h
(Gray and Bhunia 2005).

Prevalence of L. monocytogenes in food processing environments
The potential source of contamination of L. monocytogenes in processed foods,
such as fish, poultry, pork and ice cream, is often the food processing environment
(Miettinen et al. 1999; Chasseignaux et al. 2001; Fonnesbech Vogel et al. 2001; Norton et

14
al., 2001). Biofilms formed on environmental surfaces present the greatest risk for
harboring L. monocytogenes strains.
The adherence and biofilm formation of L. monocytogenes cells to food contact
surfaces have great implications on hygiene. Biofilm cells show increased resistance to
cleaning agents, disinfectants and heat, all of which are used in the sanitation of the food
processing plants. Frank and Koffi (1990) found that adherent single cells reached
undetectable levels after 12 to 16 min of exposure to the sanitizers, while planktonic cells
after 30 sec. Oh and Marshall (1995) revealed that planktonic cells were more sensitive to
heat and monolaurin than 1-day biofilm cells, which was more sensitive than 7-day
biofilm cells. The resistance might be the production of lipopolysaccharide-like
substances, which increase cell envelope lipophilicity and prevent the penetration of
sanitizers (Frank and Koffi 1990).

Adherence of L. monocytogenes to food contact surfaces
L. monocytogenes has been shown to adhere to various food contact materials
including stainless steel, polymers, glass, rubber and plastic surfaces (Helke et al. 1993;
Ronner and Wong 1993; Blackman and Frank 1996; Sinde and Carballo 2000; Beresford
et al. 2001). Surface properties of various materials accounting for the attachment of L.
monocytogenes have been examined. L. monocytogenes adherence is independent of
surface free energy for glass, stainless steel, polypropylene and rubber (Blackman and
Frank 1996; Sinde and Carballo 2000). Higher numbers of L. monocytogenes cells attach
the more hydrophobic materials, like polytetrafluorethylene and rubber, than hydrophilic
materials such as stainless steel surfaces (Sinde and Carballo 2000). Buna-N rubber has a
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bacteriostatic effect on L. monocytogenes (Ronner and Wong 1993) and a lower number
of cells were detected compared to stainless steel (Helke et al. 1993, Ronner and Wong
1993). Although differences in adherence of L. monocytogenes to different food contact
materials have been observed, these differences are not significant (Beresford et al.
2001).
Strains of L. monocytogenes differ in their ability to adhere and form biofilms on
food contact materials. The highest difference in adherence levels between strains is
approximately 100-fold (Chae and Schraft 2000). Norwood and Gilmour (1999)
examined adherence of 111 L. monocytogenes strains to stainless steel. Persistent strains
were found to adhere in significantly higher numbers than sporadic strains (Norwood and
Gilmour 1999). Among different serotypes, serotype 1/2c demonstrated significantly
better adherence than serotype 4b followed by serotype 1/2a (Norwood and Gilmour
1999). Strains producing extracellular fibrils demonstrated enhanced attachment, whereas
those non-producing strains adhere poorly (Kalmokoff et al. 2001).
L. monocytogenes strains exhibit temperature-dependent adherence to food contact
materials. Although L. monocytogenes cells are capable of adhering to surfaces at a
temperature range from 4º C to 45º C, better adherence occurred at 18ºC in monoculture
biofilms than at 4º C or 30º C (Smoot and Pierson 1998; Norwood and Gilmour 2001).
The optimum adherence at 18ºC could be due to the production of extracellular polymeric
substances (EPS) and flagella. Several studies demonstrated that both the production of
EPS and flagella were favorable at 20-21º C compared with either 10ºC or 35-37º C
(Norwood and Gilmour 2001).

16
Biofilm formation of L. monocytogenes on food contact surfaces
Nutrient level may influence biofilm formation of L. monocytogenes. The initial
biofilm development was associated with amino acid concentration, as the addition of
mannose and trehalose enhanced development (Kim and Frank 1995). Eight strains of L.
monocytogenes were examined for the biofilm development in tryptic soy broth (TSB) or
modified Welshimer's broth (MWB) at 32ºC (Moltz and Martin 2005).

Maximum

biofilm formation was formed in MWB by six strains, and in TSB by other two strains. L.
monocytogenes can be divided into three major evolutionary lines: lineage I, including
serotypes 4b, 1/2b, 3c and 3b; lineage II, including serotypes 1/2a, 1/2c and 3a; lineage
III, including 4a and 4c (Folsom and Frank 2006). In a study conducted by Folsom et al.,
(2006), biofilm accumulation of the lineage I group was better than that of the lineage II
group when grown in TSB; however, when grow in 1:10 diluted TSB, the mean biofilm
accumulation of the lineage II was better.
The vast majority of L. monocytogenes biofilms in the food-processing environment
occur as multispecies biofilms. The reported influence of competing microbes on L.
monocytogenes increases or decreases in biofilms is not constant even for the same
species. Studies have shown that the numbers of L. monocytogenes in biofilms increased
when associated with Pseudomonas fragi (Sasahara and Zottola 1993), Pseudomonas
fluorescens (Buchanan and Bagi 1999) and Flavobacterium spp. (Bremer et al., 2001).
Kocuria varians, Staphylococcus capitis, Stenotrophomonas maltophilia and Comamonas
testosteroni caused a 0.5- to 1.0-log increase of the L. monocytogenes in biofilms
(Carpentier and Chassaing 2004).
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In contrast, studies also showed L. monocytogenes gave higher cell counts in
monoculture biofilms than in a mixed biofilm with Staphylococcus sciuri (Leriche and
Carpentier 2000) or with Staphylococcus xylosus and Pseudomonas fragi (Norwood and
Gilmour 2001). Bacillus sp. and P. fluorescens led to a 3-log decrease in CFU counts
when compared to pure L. monocytogenes biofilms (Carpentier and Chassaing 2004).
Within multispecies biofilms, the combined effect of bacterial shielding and
increased production of extracellular polymeric substances (EPS), or glycocalyx, further
increase bacterial resistance to antimicrobial agents (Norwood and Gilmour 2000). L.
monocytogenes does not produce an extensive EPS network after attachment but takes
advantage of other microorganisms that do (Sasahara and Zottola 1993). Hassen et al.,
(2004) showed that L. monocytogenes survived in biofilms on condensate-forming
stainless steel by growing in EPS produced by Pseudomonas. EPS protects the L.
monocytogenes cells from the stresses of dehydration and sanitizer treatment and thus L.
monocytogenes become more difficult to remove.

Detection of L. monocytogenes in biofilms
In non-in-situ detection methods, biofilm cells are detached from the substate and
subjected to methods used for detecting planktonic cells. For example, real-time PCR was
used to estimate the number of L. monocytogenes in biofilm with detection limit of 6
×102 CFU/cm2 (Guibaud et al. 2005). The advantage of detaching cells is the ease of rapid
quantification of low levels of target bacteria. The disadvantage is the less of spatial
information about the distribution of bacteria in the biofilms. It is well known that the
plate count technique significantly underestimates the total number of cells present for a
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given biofilm. Lehtola et al. (2006) found the number of bacteria detected with FISH was
around 1×105 CFU/cm2, while it was 15-83 CFU/cm2 when analyzed with the agar
culture method. The reason for approximately 3 log difference in cell numbers is
probably due to the culture stress.
Biofilms are not simply collections of individual bacteria, but are complex
microbial communities composed of one or more species of bacteria (and/or fungi)
embedded within an extracellular matrix. These communities display discrete temporal
and spatial organization. Immuno- or molecular-based methods in combination with
confocal laser scanning microscopy (CLSM) enable in situ assessment of the distribution
and proportion of the biofilms’ pathogenic bacteria. Three-dimensional optical sectioning
by CLSM enables non-destructive study of multiple species biofilms.

In situ immunoassays
The structure and bacterial species distribution of defined species in vitro biofilms
have been analyzed using fluorescently labeled polyclonal or monoclonal antibodies
(PAb or MAb) in combination with CLSM. In a recent study presented, MAb-based
species-specific labeling of bacteria in combination with CLSM was used for detecting
specific oral bacteria and for real-time monitoring the dynamic changes of microbial flora
within oral biofilms (Gu et al., 2005). Antibody-based in situ method do not disturb the
biofilm structure and allow simultaneous assessment of the relative proportion and the
spatial arrangement of several pathogenic species within both in vitro and in vivo grown
oral biofilms.
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The detection efficiency of low levels of pathogens in biofilms relies on the
specificity of the antibody, diffusion of antibody in biofilms and the stability and
availability of antigens present on the surface of biofilm bacteria. The diffusion of
antibody in biofilm may be favored by the aqueous channels flowing in between stacks of
cells, or, blocked by the small pores within the EPS (Chavant et al., 2002). The stability
and availability of antigens present on the surface of biofilm bacteria may be influenced
by different protein patterns when grown in a biofilm situation: proteins involved in
stress response, protein synthesis and regulatory functions were up-expressed and
flagellin was down-expressed (Hefford et al., 2005). The availability of antigens may be
blocked by the presence of EPS. The capability of EPS production varies with bacteria
species, combination of bacteria species, biofilm development phases and it is also
affected by environmental pressure.

In situ hybtidization
Fluorescent in situ hybridization (FISH) is based on the specific binding of
fluorescently labeled nucleic acid probes (containing ca. 20 bases) to complementary
nucleic acid regions on targets. Ribosome RNA is an ideal target for in situ hybridization
with oligonucleotide probes because: (i) it is present in all organisms and the
identification of natural populations is based on the phylogenetic classification of 16s
rRNA sequences, (ii) a large number of sequences of different organisms are stored in
databases, (iii) the high copy number per cell greatly increases detection sensitivity and
enables the direct detection of a single cell by using an epifluorescence microscope or a
CSLM.
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FISH has become a reliable and commonly used method to detect specific bacteria,
and obtain detailed information on the spatial distribution of individual species within the
complex biofilm structure. The specificity of FISH is relatively stable because the
nucleotide sequences are not affected by many complicated biofilm factors. FISH
requires complicated specimen fixation including dehydration, probe penetration and
washing steps. Those steps are time-consuming and labor intensive and have the potential
to disrupt biofilms. Thus FISH cannot be utilized to study the dynamic changes occurring
in live biofilms.
The peptide nucleic acid (PNA)-FISH method is a promising technique for the in
situ visualization of microorganisms in biofilms. Typically, the probes used for PNA
FISH are shorter (optimum, 15 bases) than conventional DNA probes. PNA molecules
are pseudopeptides with DNA-binding capabilities. In PNA, the counterpart of the sugar
phosphate backbone of DNA and RNA is a polyamide formed by repetitive units of N-(2aminoethyl) glycine. The lack of a negative charge along the PNA backbone contributes
to very high affinity for complementary DNA and RNA sequences without electrostatic
repulsion. The hydrophobic nature of the PNA molecule allows better diffusion through
the hydrophobic cell wall of mycobacteria without out disrupting of bacterial structure
(Stender et al. 1999). Lehtola et al. (2006) report for the first time a rapid PNA nucleotide
sequence based FISH method to identify clinically important Mycobacterium avium
subsp. avium and M. avium subsp. paratuberculosis bacteria in potable-water biofilms.
Microscopic techniques ranging from optical microscopy to confocal laser scanning
microscopy is useful in evaluating bacterial morphology, biofilm internal structure and
spatial arrangement of microorganisms in biofilms. However microscopic techniques
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have some limitations. They can not quantify bacteria cells especially those from
microbial aggregates. Image analysis procedures need to be developed to provide
quantitative analysis of bacteria in biofilms.

Control of L. monocytogenes by natural antimicrobials
Food antimicrobials are compounds used to extend the lag phase or kill
microorganisms. Antimicrobials include the synthetic agents, such as acetic acid and
benzoic acid, and naturally occurring agents. Naturally occurring antimicrobials include
compounds that originate from microbial, plant and animal sources. Typical examples of
commercially used compounds are lactoferrin (from milk), lysozyme (from egg white),
saponins and flavonoids (from herbs and spices), bacteriocins (from lactic acid bacteria)
and chitosan (from shrimp shells). In recent years consumers prefer to minimally
processed or natural food products without chemical preservatives. In order to maintain
safety of food products, the food industry is looking at the use of natural antimicrobials.
In contrast to antibiotics used for therapeutic purposes, the use of natural
antimicrobials has less concern about the development of bacterial resistance (Davidson
and Harrison 2002). Bacterial resistance may result from either genetic mutation or
acquisition of resistance of genes. Because of the genetic mutation of target sites shared
by the different classes of antibiotics, cross-resistance between structurally unrelated
antibiotics is possible. Natural antimicrobials are non-specific; hence the possibility of
development of cross-resistance is very low. Compared with antibiotics, natural
antimicrobials generally have a much narrower spectrum of activity and different action
mechanisms. These characteristics reduce chances for acquired resistance.
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More importantly, some studies demonstrate that antimicrobial resistant bacteria
didn’t convey a natural advantage over non-resistant strains in food systems. Compared
to wild-type cells, pediocin resistant L. monocytogenes frequently exhibited a lower
growth rate and extended lag phase in brain heart infusion broth (Gravesen et al., 2002).
When nisin-resistant L. monocytogenes were grown in the presence of nisin, the cells
became more sensitive to heat (Modi et al. 2000).

Lysozyme
Lysozyme is an enzyme comprising 129 amino acids cross-linked by four disulfide
bonds. It is heat stable (100°C) at pH < 5.3 but is inactivated at lower temperatures when
the pH is increased (Cagri et al., 2004). It is naturally present in foods such as egg white,
cow milk, and human colostrum. It is also present in several plants, such as cauliflower
and cabbage. It is attractive as a food preservative because it is “Generally Recognized as
Safe” (GRAS). Industrial methods have been developed for its economical recovery from
egg whites, and deproteinized egg whites have been approved for food use in Europe and
recently in the United States (US FDA 2001).
Lysozyme has enzymatic activity against the β (1–4) glycosidic linkages between
N-acetyl muramic acid and N-acetyl glucosamine in the peptidoglycan layers of the
bacteria cell wall (Hughey and Johnson 1987). Damage to the structural integrity of the
cell walls results in lysis of bacterial cells. In addition, it has an antibacterial activity
independent of its enzymatic activity. Some lysozymes can kill bacteria by stimulating
autolysin activity upon interaction with the cell surface. A non-lytic bactericidal
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mechanism involving membrane damage without hydrolysis of peptidoglycan layers has
been reported (Ibrahim et al., 2001).
Lysozyme activity is variable. Gram-positive organisms tend to be more susceptible
than

gram-negative

organisms.

This

is

due

to

the

protective

lipoprotein–

lipopolysaccharide layer surrounding gram-negative bacteria (James and Simpson 1996).
Hughey and Johnson (1987) found that lysozyme has antibacterial activity against
Clostridium botulinum, L. monocytogenes and spoilage bacteria. Payne et al., (1994)
found that lysozyme (100–200 µg/ml) did not effect the growth of E. coli O157:H7, S.
Typhimurium, or P. fluorescens. Commercially, lysozyme has been used primarily to
prevent late blowing in semi-hard cheeses, which is caused by the fermentation of lactate
by butyric acid bacteria, primarily Clostridium tyrobutyricum (Bester and Lombard,
1990).

Combination of lysozyme with other antimicrobials
The effectiveness of lysozyme for controlling microorganisms is limited by its
narrow activity spectrum and high concentration required to inhibit growth. To overcome
these limitations, combinations of antimicrobials were used in food systems.

Nisin-lysozyme
The term ‘bacteriocin’ refers to a large and diverse group of extracellular
antimicrobial proteins or peptides which have bactericidal or bacteriostatic effect on other
closely related bacteria. Nisin, a bacteriocin produced by several strains of Lactococcus
lactis, is a small (3353 Da), cationic, hydrophobic, and 34-amino acid peptide (Cheigh
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and Pyun 2005). Nisin has ‘Generally Recognized as Safe’ (GRAS) status in the USA for
use in processed cheese (Delves-Broughton et al., 1996). Nisin is most effective against
lactic acid bacteria and other gram-positive bacteria, notably Clostridium, Bacillus,
Listeria, and Streptococcus (Delves-Broughton et al., 1996). Nisin alone generally does
not inhibit Gram-negative bacteria, yeasts, or molds. Nisin destroys target cells by
incorporating itself into the cytoplasmic membranes, which leads to a loss of intracellular
ions and disruption of the pH gradient and proton motive force (Bruno et al., 1992;
Breukink and De Kruijff 1999; Jydegaard et al. 2000).
It has been claimed that the antimicrobial spectrum and potency of lysozyme and
nisin can be increased when mixed together. The rationale for the increased effectiveness
is a simultaneous and synergistic attack on bacterial cells. Nattress et al., (2001)
demonstrated that the 3:1 mixture of lysozyme and nisin was more effective in inhibiting
meat spoilage bacteria, such as Carnobacterium spp. and Brochothrix thermosphacta,
than 1:1 and 1:3 ratios, or by use of lysozyme or nisin alone. The 3:1 mixture of
lysozyme and nisin was also effective at controlling the growth of a variety of lactic acid
bacteria in commercial pork products (Nattress et al., 2003).

EDTA-lysozyme
Ethylenediaminetetraacetic acid (EDTA) is a chelating agent used in a wide variety
of food products to prevent oxidation and other deteriorative reactions catalyzed by metal
ions. EDTA mediate release LPS from Gram-negative bacteria by chelating Ca and Mg
salts from the cell walls.

25
The susceptibility of Gram-negative microorganisms to lysozyme can be increased
through the use of EDTA. Gram-negative bacteria are shielded from lysozyme by LPS
anchored on the outer membrane. The use of membrane disrupting agents EDTA released
up to 50% of the LPS, and thus enabled lysozyme to reach the cytoplasmic membrane
(Branen et al, 2004).
The increased antimicrobial activity of lysozyme in combination with EDTA was
also observed for Enterococcus faecalis and Weissella viridescens (Gill et al., 2003).
EDTA in combination with lysozyme synergistically enhanced activity against L.
monocytogenes and E. coli (Branen et al., 2004). However, such synergistic inhibitory
were not bactericidal to P. fluorescens even when high concentrations of EDTA (5000–
10,000 µg/ml) were used (Branen et al., 2004).

Lactoferrin-lysozyme
Lactoferrin, a member of the transferrin protein family, is a cationic iron-binding
glycoprotein. Lactoferrin is found in many exocrine secretions, including milk, tears,
saliva and serum, and is considered as one of the most powerful antimicrobial agents in
milk. Lactoferrin is a natural alternative to EDTA for food use.
However, when lactoferrin is isolated from milk, its antimicrobial effectiveness is
greatly diminished by molecular changes resulting from pH change, heat, proteolysis, or
ionic balance. Activated Lactoferrin (ALF), a patented antimicrobial compound, provides
a stabilized form of lactoferrin which retains the desired antimicrobial properties. ALF
has been shown to be very effective at inhibiting bacterial growth including Escherichia
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coli O157:H7, Listeria monocytogenes, and Salmonella spp. It has been approved by the
USDA to prevent bacterial contamination of fresh beef (Naidu, 2002).
The synergistic effect of lactoferrin with lysozyme has been studied. Payne et al.
(1994) demonstrated that lactoferrin alone or in combination with lysozyme in Ultra High
Temperature (UHT) pasteurized milk had little practical effect against E. coli O157:H7,
P. fluorescens, S. Typhimurium or L. monocytogenes. Ellison and Giehl (1991) showed
lactoferrin (2000 µg ml−1) combined with lysozyme (500 µg ml−1) was bactericidal to
Vibrio cholera and E. coli.

Stability and activity of lysozyme in food system
Direct introduction is currently the standard method of applying antimicrobials to
food products. However interaction of antimicrobial compounds with various food
components reduces the efficacy against pathogens, and thus large concentrations of
antimicrobials are required. The effectiveness of natural antimicrobial compounds in
foods can also be limited by spontaneous loss of activity (instability), limited diffusion in
solid matrices, and inactivation through proteolytic enzymes or binding to food
ingredients such as lipids, and the emergence of antimicrobial-resistant bacteria.
Immobilization of lysozyme into or onto polymeric materials has been widely
studied recently for the purpose of enhancing its stability in complex food systems. To
improve its stability, Were et al (2004) encapsulated lysozyme into liposomes resulting in
concentrations in the range of 0.19~0.43 mg/ml depending on the lipid composition.
Conte et al (2006) immobilized lysozyme onto the surface of polyvinylalcohol films and
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found that the surface-immobilized films have a higher antimicrobial activity than bulkbound films.
Major concerns associated with the immobilization are the stability of
antimicrobials in food system and the available activity of antimicrobials to be transferred
to the target bacteria. Lysozyme has been covalently immobilized by Hotchkiss (1997);
however, its activity after immobilization was too low for practical applications. Were et
al. (2004) reported that although encapsulated nisin was more effective at inhibiting L.
monocytogenes than free nisin, encapsulated lysozyme was less effective than free
lysozyme against L. monocytogenes.
The conformation change and denaturization of antimicrobials during the
immobilization may further reduce antimicrobial activity. Release efficiency is another
factor responsible to the reduced activity because of its influence on the subsequent
interaction between antimicrobial and pathogens. The immobilized compound is released
into the packaged food in a manner of either controlled or uncontrolled. However, the
amount of diffusion of active substance needs to be well studied. High concentrations of
a released compound in food could cause sensorial or even toxicological problems,
whereas low concentrations would not be effective.

Current and potential application of nanotechnology in food safety
Nanotechnology is defined by the National Nanotechnology Initiative of NSF as
"the understanding and control of matter at dimensions of roughly 1 to 100 nanometers
(nm),

where

unique

phenomena

enable

novel

applications"

(www.nano.gov

/html/facts/whatIsNano.html). Nanobiotechnology is the convergence of biotechnology
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and nanotechnology. Because of unique optical properties, high surface-to-volume ratio,
and other size-dependent qualities, nanomaterials offer more diverse capabilities in
bioanalysis and biotechnological applications. Thus far, nanomaterials have found
applications in bioimaging, biosensing, drug delivery and design of multifunctional
nanodevices (Chan 2006).
The food industry is turning to nanotechnology as it searches for innovations that
could bring safer, healthier, and tastier products to consumers. The two major prospects
for nanotechnology in improving food safety include production of biosensors for
detecting the pathogens and toxins in foods and food processing establishments, and
immobilization of antimicrobials on nanomaterials for enhanced stability and activity.

Detection of pathogenic bacteria
The conjugation of biomolecules with nanomaterials is the foundation of
nanobiorecognition. Biomolecules, such as proteins, carbohydrate and DNA, are highly
selective in terms of their unique interactions with the corresponding targets. Taking
advantages of the unique electronic, optical and magnetic properties of nanomaterials,
bioconjugated-nanomaterials provide a novel field in developing nanobiotechnology in
microorganism detection.

Bacterial recognition by functionalized nanomaterials
Antibody-antigen reactions are the basis for immunoassays. For bacteria, there are
many surface antigens available for specific recognition by using antibody conjugated
nanomaterials. For example, Dr. Sun’s group has revealed the specific recognition of
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pathogenic E. coli O157:H7 with carbon nanotubes functionalized with anti-E. coli O157
(Gu et al., 2004; Elkin et al., 2005).
The biomolecules involved in adhesin-receptor interaction may serve as a platform
for nanomaterial modification. A variety of carbohydrates have been recognized as
receptors for attachment of pathogenic microorganisms to epithelial cells. As an example,
galactose, glucose, fructose, fucose, mannose and sucrose were corresponding
carbohydrate receptors on epithelial cells for the adhesins of E. coli (Sharon 2006). Dr.
Sun’s group functionalized carbon nanotubes with E. coli receptors: galactoses or
mannose (Gu et al., 2004; Qu et al., 2005). Those carbohydrate-conjugated nanomaterials
displayed strongly adhesion-specific interaction with E. coli.
Vancomycin, a glycopeptide antibiotic, was applied to recognize Gram-positive
bacteria by its binding to terminal peptide (D-Ala-D-Ala) on the cell walls via hydrogen
bonds. Lin et al. (2005) employed vancomycin-modified magnetic nanoparticles for
selectively isolating of Gram-positive pathogens from sample solutions. The isolated
cells were characterized by matrix-assisted laser desorption/ionization mass spectrometry
(MALDI-MS), a straightforward means to differentiate microorganism species based on
mass spectral fingerprinting. The lowest detection for both Staphylococcus saprophyticus
and Staphylococcus aureus in a urine sample was ~7 ×104 CFU/ml. Recently, Gu et al.,
(2006) demonstrated that vancomycin functionalized magnetic nanoparticles were able to
capture pathogenic bacteria, such as Enterococci and Staphylococcus, at concentrations
of less than 102 CFU/ml.
Nucleic acid sequences are unique to every living organism. Its property of
interacting with complementary DNA sequences has been exploited for bacterial
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recognition. Amagliani et al. (2006) immobilized oligonucleotide prodes to magnetic
nanoparticle for selective DNA purification. Followed by PCR, L. monocytogenes cells
were detected from milk samples at a 10 CFU/ml contamination rate. However, a dosedependent inhibitory effect of the nanoparticles on PCR was observed.
Various biomolecules contain several binding sites, for example, antibodies exhibit
two antigen-binding fragment sites, streptavidin displays four binding domains, and
oligonucleotide pairs have multiple complementary binding sites. These cross-linking
features of the biomolecule provide a flexible means of generating biomolecule–
nanomaterial aggregates. During the biorecognition process, aggregations between
nanomaterials and microorganisms were often observed (Varshney et al. 2005; Qu et al.
2005; Gu et al., 2006). The nanomaterials mediated aggregation may potentially serve as
bio-detergents for the specific expulsion of pathogenic bacteria from complex biosystem.

Use of nanomaterials for improved detection sensitivity
Taking advantage of the high surface-to-volume ratio and faster reaction kinetics
functionalized

magnetic

nanomaterials

display

higher

capture

efficiencies

in

immunomagnetic separation than microbeads do. A minimum capture efficiency of 94%
for E. coli O157:H7 ranging from 1.6 x 101 to 7.2 x 107 CFU/ml was reported by using
magnetic nanoparticle-anti-E. coli conjugates (Varshney et al. 2005). In the presence of S.
Typhimurium DT104 cells as background flora, carbon magnetic nanotubes conjugated
with anti-E. coli O157 were capable of capturing E. coli O157:H7 at a relatively low
concentration of 40 CFU/0.1 ml without cross reaction between species (Lin et al. 2006).
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Recently, dye-doped nanoparticles were developed as markers for bio-analytical
applications due to their favorable properties such as high fluorescence quantum yields,
photostability, and tunable fluorescence bands. A single nanoparticle of diameter about
100 nm contained hundreds of fluorescent dyes. Thus dye-doped nanoparticles are much
brighter than single fluorescent dye (Lian, et al., 2004). Zhao et al. (2004) developed a
bioassay based on fluorescent nanoparticles conjugated with anti-O157 for in situ
detection of a single bacterial cell within 20 min.
The protein G-tagged liposomal nanovesicles were successfully used in an
immunomagnetic bead sandwich assay for the detection of E. coli O157:H7 with a
detection limit of approximately 100 CFU/ml (Chen et al., 2005). Each liposomal
nanovesicle, i.e., liposome, can contain up to several million fluorescent dye molecules.
Because of providing greatly enhanced signals, liposomal nanovesicles have been
successfully used as reporter particles in immunoassays.

Use of nanomaterials for detecting multiple microorganisms
The optical properties of nanomaterials, such as emissive, absorptive, and lightscattering properties, are directly related to their sizes, composition, and shapes. For
example, both the absorption and emission energies of quantum dots shift to higher
energies as the size of the nanoparticles decreases (Bruchez et al., 1998). These features
make nanomaterials ideal for multiplexed detection. Yang and Li (2006) explored the use
of semiconductor quantum dots as fluorescence labels in immunoassays for simultaneous
detection of two species of foodborne pathogens, E. coli O157:H7 and S. Typhimurium.
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The varying numbers and ratios of different quantum dots per target result in a unique
fluorescent signal for each individual target.
An immunomagnetic bead sandwich assay using universal G-liposomal
nanovesicles was developed to simultaneously detect E. coli O157:H7, Salmonella spp.,
and Listeria monocytogenes with detection limits of 3.1 x 103, 7.8 x 104, and 7.9 x 105
CFU/ml, respectively (Chen et al., 2006).

Use of nanomaterials for development of biosensors
Those pioneering studies mentioned above are not only fundamentally important
but also critical to the development of practical biosensors. Because of its small size, a
target binding event involving the nanomaterial can have a significant effect on its
physical and chemical properties, thereby providing a mode of signal transduction or
amplification which is not available with a bulk structure made of the same material.
Basu et al. (2004) used anti-E. coli-bound gold nanowire arrays (GNWA) prepared
on anodized porous alumina template for capturing E. coli 0157:H7. The bacteriaantibody complex formation will change the surface properties of the sensor, such as
capacitance of the biomembrane. Such change was measured by electrochemical
impedance spectroscopy (EIS) and then the amount of bound E. coli was determined.
Their preliminary results indicated that the GNWA biosensor could detect 50 E. coli cells
with the sensor area of 0.178 cm2.
In a study carried by Zhou et al (2006), the attachment of single-walled nanotubes
(SWNT)

enhanced

and

reversed

bacteria

dielectrophoresis

(DEP)

mobility.

Consequently, the SWNT–bacteria aggregates assemble rapidly (< 5 min) into
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conducting bridges between two electrodes by positive-alternating current DEP. This
strategy showed a detection threshold of 104 CFU/ml of E. coli. Incorporation of
functionalized SWNT will led SWNT play a more specific role as absorbers and
transporters of pathogens in biosensors.

Nanostructure-mediated antimicrobial delivery
Polymeric nanoparticles have been studied as drug carriers in the past 20 years. The
objective in developing these nanocarriers is the controlled drug release and targeted drug
delivery. Polymeric nanoparticle-mediated drug delivery is advantageous in a number of
ways. First, they possess the high drug-loading capacities, thereby increasing intracellular
delivery of the drug. Secondly, the solid matrix of particulate carriers protects the
incorporated antimicrobials against degradation, thus increasing the chances of reaching
targets and reducing the amount of those compounds used. Finally, nanoscale drug
targeting is enabling the delivery of chemotherapy agents directly to cells and tumors
within healthy tissue, resulting in reduced drug toxicity and more efficient drug
distribution.

Drug targeting
Drug targeting may be classified into two general methods: passive and active
targeting. In passive targeting, target/nontarget ratio of the quantity of drug delivered is
increased by adjusting the properties of carrier systems to the characteristics of the targets
and nontargets. Both chemical and physical characteristics of target cells may influence
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passive

targeting.

The

former

includes

hydrophilicity/hydrophobicity

and

positive/negative charge and the later includes size and mass (Yokoyama 2005).
Active targeting involves the surface function of drug carriers with molecules which
enabl them to be selectively attached to target cells. These selective interactions include
antigen–antibody and ligand–receptor binding. Alternatively, physical signals such as
magnetic fields and temperatures may be utilized for active targeting by their external
application to the target sites. The activive targeting is highly selective and thus allows a
more precise drug delivery to the site of interest (Yokoyama 2005).

Drug release
Through precise control of the drug carrier structure, the release of the drug can be
tuned to achieve a desired kinetic profile. Three of the most common kinetic profiles are
zero order, first order, and Higuchi; these are expressed mathematically in Eq:
1) Zero order: Dt=D0+k0t
2) First order: ln Dt =ln D0+k1t
3) Higuchi: Dt = D0=kHt1⁄2
Where Dt is the amount of drug released at time t, D0 is the initial amount of drug
released, result of initial rapid release, k0 is the zero-order release constant, k1 is the firstorder release constant, and kH is the Higuchi release constant (Kefalides 1998; Hughes
2005). The ideal release profile for most drugs would follow zero-order kinetics, a steady
release rate so that the drug levels in the body remain constant while the drug is being
administered.
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Fig 1.1 Drug release profiles from zero order, first order and higuchi order (Hughes
2005).

The prediction of the drug release from biodegradable polymeric nanoparticles is
complex because it results from a combined effect of various parameters: desorption of
the surface-bound/adsorbed drug, diffusion through the polymer matrix, degradation rate
of the polymer and the combined erosion/diffusion process (Soppimath et al., 2001).
Release of drug from the nanoparticles of matrix type follows the first-order kinetics
(Soppimath et al., 2001; LaVan et al., 2003). It occurs on two different time scales: the
initial rapid release is due to the diffusion of the drug that was present outside the
nanoparticles and the slower release is due to diffusion of the drug that was trapped
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inside the particles. Drug release from nanocapsules should theoretically follow the zeroorder kinetics since the release occurs by diffusion of the drug from the core across the
polymeric barrier layer (Soppimath et al., 2001; LaVan et al., 2003).

Enhanced activity of antimicrobials on nanomaterials
Ampicillin-bound nanoparticle of polyisohexylcyanoacrylate was used for treatment
of experimental salmonellosis in mice (Fattal et al., 1989). Compared with three doses of
32 mg each of ampicillin, a similar curative effect was achieved by a single injection of
0.8 mg of nanoparticle-bound ampicillin. The efficacy of ampicillin-bound nanoparticles
was also studied in vitro in mouse peritoneal macrophages infected with L.
monocytogenes (Forestier et al., 1992). With the same concentration of ampicillin of 1
mg/L, the viable counts of L. monocytogenes after 30 h was 3.68 log10 CFU/ml for
ampicillin-bound nanoparticles, while 5.43 log10 CFU/ml for free ampicillin.
Ploy-nanoparticles (lactide-co-glycolide) bound with anti-tuberculosis drug
(rifampin, isoniazid, and pyrazinamide) were applied to Mycobacterium tuberculosis–
infected guinea pigs (Pandey 2003). No tubercle bacilli could be detected in the lung after
only five doses of treatment at every 10th day, whereas 46 daily doses of orally
administered drug were required to obtain an equivalent therapeutic benefit.
Antimicrobial activity of ciprofloxacin-loaded poly-nanoparticles against Pseudomonas
aeruginosa and S. aureus was comparable with an equally concentrated ciprofloxacin
solution (Dillen et al., 2006). Quaternary ammonium-bound polyethylenimine (PEI)
nanoparticles were immobilized on resin-based dental materials (Beyth et al., 2006). The
antibacterial activity against Streptoccocus mutans lasted for at least 1 month.
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Metallic nanomaterials themselves are known to have antibacterial effects. Silver
nanoparticles are found effective to both Gram-negative bacteria including E. coli, P.
aeruginosa and S. typhus and Gram-positive Staphylococcus epidermidis (Sondi and
Salopek-Sondi 2004; Furno et al., 2004; Melaiye et al., 2005). Deposition of silver on
nanoparticles of titanium dioxide significantly increases its bacteriocidal effects against
E. coli (Kim et al., 2006). Silver nanoparticles in combination with amoxicillin resulted
in a synergistic effect against E. coli, which was greater than when they applied
separately (Li et al., 2005). Vancomycin-capped gold nanoparticles exhibited enhanced
activities against vancomycin-resistant enterococci (VRE) stains and Gram-negative E.
coli (Gu et al., 2004).

Toxicity concerns
It is reported that drug entrapment efficiency can reach more than 80% and drug
content up to 50% (Peracchia et al., 1997); however, in most cases, drug contents are 510% (wt/wt) of nanoparticle weights or even less (Dong and Feng 2004). Thus, generally
as high as 90% of the material to be administered will likely be nanoparticle. At present,
nanomaterials toxicity is still inconclusive. Due to the potential toxicity of nanomaterials,
biodegradable nanoparticles of gelatin and human serum albumin show promise as
antimicrobial carriers (Brzoska et al., 2004).
The toxicity of nanomaterials depends on their size, shape, phase composition and
surface characteristics. The prediction of toxicity of a certain nanoparticle requires a
comprehensive set of in vitro and in vivo experiment. In principle, nanomaterials larger
than 400 nm in diameter are easily and rapidly captured by the reticuloendothelial
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systems because of the nonspecific scavenging. On the other hand, it is known that
macromolecules with molecular weights smaller than ca. 40, 000 (~5 nm) are excreted
through the renal filtration system. Therefore, nanoparticle size of smaller than 5 nm in
diameter is intentionally used in some cases for a complete excretion especially for nonbiodegradable polymeric nanoparticle.
Sayes et al (2006) demonstrated that cytotoxicity was correlated to the phase
composition of the nanoscale titania. Anatase TiO2 was 100 times more toxic than an
equivalent sample of rutile TiO2. The nanoparticle samples most effective at generating
reactive oxygen species were also the most cytotoxic.
Carbon nanotubes are highly toxic mainly due to their insolubility. The proper
functionization is of fundamental importance to carbon nanotube safety. It has been
observed that single-walled nanotubes (SWNTs) are less cytotoxic against human
macrophage cells when highly purified and containing only traces of metal catalysts and
graphite than un-purified SWNT (Fiorito et al., 2006). Shi Kam et al. (2004) reported that
the cellular uptake of carbon nanotubes-protein conjugates appeared to be passive and
endocytosis-independent. Cai et al. (2005) demonstrated that carbon nanotubes
pernetrated and diffused through the lipid bilayer of plasma membrane without apparent
toxic effects.
The toxicity of nanoparticles is dose-dependent. Single dose or short time
application over one or two weeks probably will not cause serious health problems. The
problems will arise, if poorly soluble particles and non biodegradable particles are used
for long term or life time therapy like diabetes, asthma or rheumatoides (Warheit et al.,
2004). Sayes et al (2006) reported that only at relatively high concentrations (100 mg/ml)
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of nanoscale titania the cytotoxicity and inflammation were observed. Those cellular
responses exhibited classic dose-response behavior, and the effects increased with time of
exposure.
Concerns about nanoparticles toxicity must be addressed before the administration
of nanoparticles. There were toxicity investigations on similar nanoparticles as those used
in our experiments through collaboration between Clemson researchers and NC-State
researchers, and the unpublished results found no toxic effects on the health of the
animals (young turkeys).

Statement of problem
We have chosen L. monocytogenes as it is one of the most dangerous food-borne
pathogens. L. monocytogenes causes severe disease with high fatality rates with a low
dose of infection. Given the “zero-tolerance” policy, the presence of even a single
bacterium in food poses a serious health risk. Therefore, rapid and sensitive detection as
well as effective inhibition of L. monocytogenes in foods and in biofilms is critical to
minimize and eliminate potential infections.
Each antibody-conjugated nanoparticles (immunonanoparticles) with diameter of
around 100 nm could efficiently conjugate more than 100 molecules of primary antibody
providing improved affinity to antigen (Soukka et al., 2001). For a bacterial cell, there are
many surface antigens available for specific recognition using immunonanoparticles.
Therefore, it is possible to have thousands of immunonanoparticles bind to each bacterial
cell. Application of immunonanoparticles enables the development of a sensitive method
capable of detecting a few pathogenic cells in foods and food processing environments.
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Immunonanoparticles will also have useful applications in the fields of specific deliver of
antimicrobial to target pathogens in food system.
The objectives of this study were:
1. Detection of L. monocytogenes in biofilms using immunonanoparticles.
2. Rapid

detection

of

L.

monocytogenes

by

nanoparticle-based

immunomagnetic separation and real-time PCR.
3. Enhancing antimicrobial activity of lysozyme against L. monocytogenes
using immunonanoparticles.
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CHAPTER TWO
DETECTION OF LISTERIA MONOCYTOGENES IN BIOFILMS USING
IMMUNONANOPARTICLES

Abstract
Listeria monocytogenes can form biofilms on food contact surfaces and processing
environment, and becomes more resistant to routine cleaning and sanitation treatments.
Thus, the detection of L. monocytogenes in biofilms has attracted increasing attention for
the microbiological safety of food. In this study, a nanoparticle-based immunoassay was
developed for the sensitive detection of L. monocytogenes in biofilms. L. monocytogenes
Scott A labeled with green fluorescent protein (GFP) was grown on glass slide to form a
mono-species biofilm, or co-cultured with Pseudomonas aeruginosa ATCC 27853 to
form a two-species biofilm. The anti-L. monocytogenes-coated nanoparticles specifically
recognized L. monocytogenes in monospecies biofilms. However, under the same laser
scanning confocal microscopy conditions, anti-L. monocytogenes-nanoparticles generated
higher intensity of fluorescent signals, which ranged from 0 to 4000, than anti-L.
monocytogenes alone did, which was in the range of 0 to 250. In two-species biofilms, L.
monocytogenes cells at different depths (0-3 µm) of biofilms were successfully detected
by both nanoparticle-based indirect immunoassay and fluorescent nanoparticle-based
direct

immunoassay.

Our

results

demonstrate

that

these

nanoparticle-based

immunoassays were more sensitive than traditional immunoassays for detecting of L.
monocytogenes in mono- or two-species biofilms. Pathogen cells at different depths of
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the biofilms could also be detected by such immunoassays in combination with confocal
microscopy analyses.
Introduction
Listeria monocytogenes is a psychrotrophic gram-positive pathogen frequently
involved in outbreaks of food-borne disease related to consumption of contaminated
milk, cheese, meat, and vegetable (McLauchlin, 1996). The major source of
contamination of L. monocytogenes for processed foods is the food processing
environment, such as dairy processing plants (Jeong and Frank, 1994), meat processing
plants (Gibbons, et al., 2006) and vegetable processing facilities (Hines, 1999). The cold
and wet environments in a food processing plant create ideal conditions for the growth
and survival of L. monocytogenes. Frequently, this pathogen forms biofilms on common
food contact surfaces such as plastic, polytetrafluoroethylene, polypropylene, rubber,
stainless steel and glass (Blackman and Frank, 1996; Carpentier and Chassaing, 2004;
Chavant et al., 2002; Jeong and Frank, 1994; Kim and Frank, 1995; Mafu et al., 1990;
Sasahara and Zottola, 1993). Inside biofilms L. monocytogenes cells become more
resistant than planktonic cells to routine sanitizing procedures and, thus, were more
difficult to remove (Chmielewski and Frank, 2003; Frank, et al., 1990). Formation of
bacterial biofilms is generally described as a dynamic event, including initial attachment
to the target surfaces, maturation of attached bacteria into a differentiated biofilm
surrounded by a matrix of exopolymers, and dispersal of planktonic cells from biofilms
(Costerton and Lewandowski, 1995; Costerton et al., 1999). The dispersal of L.
monocytogenes cells from biofilms is a source of contamination for the finished food
products (Jeong and Frank, 1994; Kim and Frank 1995). Thus, there is an increasing
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concern in the food industry with the growth and presence of L. monocytogenes in
biofilms.
Rapid detection of L. monocytogenes in biofilms is a crucial step for ensuring food
safety. Fluorescent in situ hybridization (FISH) and in situ fluorescent immunoassay
(ISFA) represent two main assay formats to study the relative ratio and spatial
distribution of pathogenic bacteria in biofilms (Aoi, 2002; Gu et al., 2005; Thurnheer et
al., 2004). FISH, applying fluorescently labeled DNA probes to complementary DNA
sequences inside cells, is specific but labor intensive and time consuming. In contrast,
immunological methods based on the specific recognition between antibodies and
antigens on the cell surfaces are easier to perform, and the binding between specific
antibody and target cells does not require destruction of the cell and tissue structure. Noninvasive immunoassay in combination with confocal laser scanning microscopy (CLSM)
enables real-time monitoring of the dynamic changes involved in biofilm formation (Gu
et al., 2005). However, the detection of pathogenic bacteria in biofilms by fluorescence
immunoassays is limited by their sensitivity due to low-abundance of targets in the
biofilms.
Immunonanoparticles have been suggested as a novel tool in the development of
ultra-sensitive immunoassays (Soukka et al., 2003; Valanne et al., 2005; Varshney et al.,
2005; Zhao et al., 2004). Bio-molecules such as antibodies and streptavidin can easily be
conjugated to the surfaces of nanoparticles through covalent binding (Lian et al., 2004;
Soukka et al., 2001; Soukka et al., 2003; Valanne et al., 2005). Using the multivalent
nanoparticle-antibody-bioconjugates in the immunoassay, the sensitivity of the assay can
be improved substantially. Immunonanomaterials have demonstrated their unique
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advantages in separation and identification of foodborne pathogens (Elkin et al., 2005; Gu
et al., 2005; Varshney et al., 2005; Zhao et al., 2004;), clinical diagnostics (Soukka et al.,
2003; Valanne et al., 2005) and other bio-analysis (Lian et al., 2004).
Although the application of immunonanoparticle for biological analysis has been
reported, it has not been applied to high resolution examination of biofilms using
fluorescence microscopy. In this study, we evaluated the potential of using anti-Listeriaconjugated nanoparticles for sensitive detection of L. monocytogenes in biofilms.

Materials and Methods
Microorganisms and culture conditions
Listeria monocytogenes Scott A labeled with green fluorescent protein (GFP) and
Pseudomonas aeruginosa ATCC 27853 were used in this study. These cultures were
stored at -80°C as stock. Each strain was subcultured twice on tryptic soy agar (TSA;
Difco, Detroit, Michigan) before being used in the following experiments. GFP-labeled L.
monocytogenes Scott A was grown in tryptic soy broth (TSB; Difco, Detroit, Michigan)
supplemented with erythromycin (8 µg/ml) overnight at 37°C. P. aeruginosa ATCC
27853 was grown in TSB, instead. The overnight cultures were washed twice with
phosphate-buffered saline (PBS). The cell concentration of each culture was adjusted to
an optical density (OD) of 0.5 at 600 nm (ca. 5×108 CFU/ml).
Formation of biofilms on glass slides
Monospecies biofilms were formed by L. monocytogenes Scott A using a static
model as described by Chae and Schraft (2000) with slight modification. Briefly, 100 µl
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of L. monocytogenes Scott A suspension was deposited evenly on the 1.3×1.3 cm marked
area of the glass slides. The slides were placed on top of a leveled rack and then put
inside a chamber with ca. 2.5 cm depth of saturated K2SO4 (Fisher Scientific, Fairlawn,
NJ) on the bottom to keep moisture retention on the slides. After 3-h incubation, the nonadherent bacterial cells on each slide were removed by washing with 10 ml of PBS twice,
followed by the deposition of 100 µl of TSB and incubation at 37°C for up to 6 days.
Finally the glass slides were removed from the incubator and rinsed with PBS to remove
any unattached cells.
Two-species biofilms of L. monocytogenes Scott A and P. aeruginosa ATCC
27853 were prepared by depositing the bacterial culture mixture consisting of 75 µl L.
monocytogenes Scott A and 25 µl P. aeruginosa ATCC 27853 cultures on glass slides.
Both the incubation and wash conditions were the same as those described for
monospecies biofilms.
Synthesis and surface modification of nanoparticles
Carboxyl-modified polystyrene nanoparticles with or without embedded
fluorescent dye (1,1’-dihexadecyl-3,3,3’,3’- tetramethylindocarbocyanine perchlorate, or
DiI) were both synthesized via miniemulsion polymerization. In a typical reaction for the
preparation of the carboxyl-modified polystyrene nanoparticles, the organic phase
[styrene (1.50 g, 14.4 mmol), 2,2’-azobis(2-methylpropionitrile) (AIBN, 50 mg, 0.3
mmol), and hexadecane (60 mg, 0.26 mmol)] and the aqueous phase [sodium
dodecylsulfate (SDS, 50 mg, 0.17 mmol), a styrene-based macromonomer with a PEG
tether and a carboxyl end group (750 mg, 0.33 mmol) (Qu, et al. 2005), and deionized
water (24 ml)] were prepared separately. After both purging with nitrogen for 5 min, the
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organic phase was dispersed into the aqueous one for pre-emulsification for 1 h. The
mixture was sonicated in an ice-cooled bath for 2 min to form the miniemulsion, which
was then heated to 70oC and kept for 24 h with a steady stirring at 400 rpm. The milky
mixture was transferred to a cellulose membrane tubing (cut-off molecular weight
~12,000, Spectrum Laboratories) for dialysis against fresh deionized water for 3 days to
obtain the suspension of the carboxyl-modified polystyrene nanoparticles (solid content
1.8 w.t.%). The carboxyl-modified fluorescent polystyrene nanoparticles (with embedded
DiI) were prepared in essentially the same procedure, except for the inclusion of DiI (1
mg, 0.001 mmol) in the organic phase when preparing the miniemulsion. Both
transmission electron microscopy and dynamic light scattering measurements were used
to further characterize these nanoparticles.
Preparation of immunonanoparticles
Carboxyl-modified polystyrene nanoparticles were covalently bound with rabbit
anti-L. monocytogenes (Biodesign international, ME) via the amine groups following a
protocol described previously by Soukka et al. (2001). Briefly, 100 µl of nanoparticles
were washed with deionized water and then activated in a 1ml solution of 2% 1-ethyl-3(3-dimethylaminopropyl) carbodiimide hydrochloride (pH 5.6) (Sigma-Aldrich, St. Louis,
MO) for 40 minutes at room temperature. Then carbodiimide-activated nanoparticles
were washed with 500 µl of 0.2 M borate buffer and mixed with 40 µg of rabbit anti-L.
monocytogenes in 500 µl of 0.2 M borate buffer (pH 8.5). The mixture was rotated at 30
rpm for overnight at room temperature, and then centrifuged at 14,000 g to remove free
antibody. The pellet was washed and resuspended in 100 µl of wash/storage buffer [0.1
M glycine-saline containing 0.2% NaN3 , 0.05% Tween-20 and 0.2% bovine serum
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albumin (BSA) (Sigma, St. Louis, MO), pH 8.5]. The resulting anti-L.monocytogenesnanoparticles were stored at 4°C.
Anti-L. monocytogenes-fluorescent-nanoparticles were prepared by coating 100
µl of DiI-embeded fluorescent nanoparticles with 40 µg of rabbit anti-L. monocytogenes
and stored at 4°C as described above. Due to the washing step for removing unbound
antibody, the concentration of anti-L. monocytogenes coated on 100 µl of
immunonanoparticles was less than 40 µg/100µl.
Immunoassays
For indirect fluorescent immunoassays, biofilm slides were washed with 20 ml of
PBS-BSA, incubated with 30 µl of rabbit anti-L. monocytogenes (40 µg/100 µl) or 30 µl
of anti-L. monocytogenes-nanoparticles for 30 min at 37°C. The slides were washed with
PBS containing 0.2% BSA (PBS-BSA) and then incubated with 30 µl of a secondary
antibody, rhodamine-labeled goat anti-rabbit IgG (50 µg/ml) (KPL, Gaithersburg, MD),
for 30 min at 37°C, followed by washing twice with 10 ml of PBS-BSA.
For direct fluorescent immunoassay, biofilm slides were washed with PBS-BSA
buffer, incubated with 30 µl of anti-L. monocytogenes-fluorescent-nanoparticles for 30
min at 37°C, and washed with PBS-BSA buffer again.
Confocal laser scanning microscopy
Soon after in situ immunoassay, the microscope slides with biofilms were sealed
by a glass cover. All microscopic observations and image acquisitions were performed on
a confocal scanning laser microscope (LSM 510, Carl Zeiss, Germany). Confocal
microscopy was performed using argon ion (488 nm) and HeNe (543 nm) lasers for the
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excitations with a 510-530 nm bandpass and a 560 nm longpass emission filter,
respectively, for emission image collection. Z-series were generated by taking a series of
vertical optical sections at intervals of 1 µm throughout the full depth of the biofilms.
Microscopic parameters, e.g. detector gain, amplification offset, amplification gain,
pixels and pin hole, were set congruously for images acquired with the purpose of
fluorescence intensity comparison. All the images were acquired and analyzed by the
software package equipped with the microscope (Zeiss LSM 510, version 2.8).

Results and Discussion
In this study, the carboxyl-modified polystyrene nanoparticles with or without
embedded fluorescent dye were both synthesized via miniemulsion polymerization. The
two types of nanoparticles were of ~100 nm in diameter (Fig. 2.1), while the fluorescent
nanoparticles could be conveniently observed via confocal microscopy (Fig. 2.1B). In
addition, L.monocytogenes was labeled with the green fluorescent protein (GFP) for easy
observation under confocal scanning laser microscopy (CSLM). Red fluorescence signal
from either rhodamine-labeled secondary antibody in indirect immunoassay or DiI-doped
fluorescent nanoparticles in direct immunoassay is an indication of the presence of
nanoparticles in biofilms. Yellow signal, the overlay of green and red fluorescence,
indicates that L.monocytogenes cells in biofilms were successfully detected by
immunonanoparticles. The ideal situation is that the presence of L. monocytogenes should
be associated with the occurrence of red fluorescence. The presence of L. monocytogenes
with the absence of red fluorescence is considered as false negative, whereas the
detection of red fluorescence with the absence of L. monocytogenes is considered as false
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positive. Since the goal of this study was to use the red fluorescence generated by antigen
and immunonanoparticle recognition for rapid and sensitive detection of the L.
monocytogenes in biofilms, CSLM was used for examining the co-localization of the
immunonanoparticles and L. monocytogenes cells.
Detection of L. monocytogenes in monospecies biofilms
Microscopic observation revealed that L. monocytogenes Scott A formed biofilms
on the surface of glass slide within 48-72 h of incubation. From ca.72 to 148 h, the
population of L. monocytogenes Scott A in the biofilms was relatively constant.
However, after a long incubation time, usually > 148 h, bacterial cells started to detach
from the surface (data not shown). Therefore, the 72~96 h-old biofilms were used in our
study for detecting L. monocytogenes in monospecies biofilms (Fig. 2.2A).
Two indirect immunoassays, with free anti-L. monocytogenes and anti-L.
monocytogenes-nanoparticle,

respectively,

were

applied

for

detection

of

L.

monocytogenes in monospecies biofilms. Confocal laser scanning microscopy (CLSM)
images revealed the co-localization of L. monocytogenes with either free anti-L.
monocytogenes (Fig. 2.2B) or anti-L. monocytogenes-nanoparticles (Fig. 2.2C),
indicating that both detection methods specifically recognized L. monocytogenes in the
monospecies biofilms. Apparently, the conjugation of anti-L. monocytogenes to
nanoparticles did not block the antigen recognition sites of the antibody. Moreover, under
the same CLSM conditions, anti-L. monocytogenes-nanoparticles generated higher
intensity of fluorescent signals, which ranged from 0 to 4000 (Fig. 2.3B), than free anti-L.
monocytogenes did, which was in the range of 0 to 250 (Fig. 2.3A).
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Coating antibody molecules on nanoparticles allows multiple contacts between
single

nanoparticle

and

specific

bacterial

surface

antigens,

and

therefore,

immunonanoparticles display higher binding affinity toward antigens than free antibody.
Soukka et al. (2001) demonstrated that the binding affinity constant for antibodynanoparticle bioconjugates was 8-fold higher than the intrinsic affinity of the free
antibody. Each nanoparticle with diameter of around 100 nm could efficiently conjugate
about 150-200 molecules of antibody and resulted in more than 300 active binding sites
(two binding sites for each antibody) (Lian et al., 2004; Soukka et al., 2003; Valanne et
al., 2005). Due to the binding of fluorescence-labeled secondary antibody to multiple
primary antibody molecules on nanoparticles, nanoparticles-based immunoassay
displayed enhanced signal intensity than conventional immunoassays.
Detection of L.monocytogenes in the two-species biofilms
In general, L. monocytogenes forms biofilms with other bacterial species in foodprocessing environments. Pseudomonas spp., considered as a good biofilm former, is
commonly found in the food-processing environments. Both adhesion and growth of L.
monocytogenes in biofilms may be affected by the co-existence with Pseudomonas spp.
(Hassan et al., 2004; Jeong and Frank, 1994; Sasahara and Zottola, 1993). In this study, P.
aeruginosa ATCC 27853 was co-cultured with L. monocytogenes to form two-species
biofilms. CLSM images revealed that L. monocytogenes in the 96 h-old two-species
biofilms existed as scattered single cells among large population of P. aeruginosa. L.
monocytogenes cells were successfully detected through both indirect immunoassay
using anti-L. monocytogenes-nanoparticles and direct immunoassay using anti-L.
monocytogenes-fluorescent-nanoparticles (Fig. 2.4B and 2.4C). However, when anti-L.
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monocytogenes itself was used under the same experimental conditions, no colocalization signal was detectable in a two-species biofilm (Fig. 2.4A). As described in
materials and methods, the concentration of anti-L.monocytogenes coated on
immunonanoparticles was less than that of corresponding anti-L.monocytogenes solution
(40 µg/100 µl). Since equal amounts of anti-L. monocytogenes solution and
immunonanoparticles were applied to each immunoassay reaction, these results strongly
suggest that immunonanoparticle-based immunoassays were much more sensitive than
conventional immunoassays.
Undoubtedly, the specific detection of L. monocytogenes is more challenging in
multispecies biofilms than in monospecies biofilms. Effective detection of L.
monocytogenes in two-species could be affected by the following factors. First, the
stability of antigens present on the surfaces of L. monocytogenes Scott A might be
influenced by the presence of competing microorganisms. L. monocytogenes exhibit
different protein patterns when growing in a biofilm environment. For instance, proteins
involved in stress response and metabolism were up-expressed; however, flagellin was
down-expressed during the biofilm development of L. monocytogenes (Hefford et al.,
2005; Trémoulet et al., 2002). Secondly, the antibody binding regions of antigens might
be blocked by the presence of extracellular polymeric substances (EPS) in a multispeciesbiofilm situation. L. monocytogenes cells do not produce an extensive EPS network;
however, Pseudomonas spp. has been previously reported as good producer of EPS
(Sasahara and Zottola, 1993). A study by Hassan et al. (2004) indicated that the presence
of Pseudomonas spp. in biofilms may benefit the survival of L. monocytogenes by
producing EPS or, less likely, stimulating L. monocytogenes to grow in the EPS layer.
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Thirdly, the target L. monocytogenes distributed in two-species biofilms as scattered
single cells might lead to some difficulty in primary antibody recognition, especially for
conventional immunoassays which depend on single-molecular interaction and
recognition between the antibody and antigen. Fourthly, even if L. monocytogenes cells
had been specifically recognized by primary antibody, fluorescence from the binding of
fluorescence-labeled secondary antibody would not be strong enough to be detected due
to the relatively low intensity of fluorescent dye.
The advantage of nanoparticle-based immunoassays over conventional assays
should attribute to the higher binding affinity and signal amplification by using
immunonanoparticles. It is worth to note that anti-L. monocytogenes-fluorescentnanoparticles achieved a signal amplification in a different way than anti-L.
monocytogenes-nanoparticles described above. A single fluorescent nanoparticle with a
diameter of ~100 nm contained hundreds of fluorescent dye molecules and thus, was
much brighter than a single dye molecule (Härmä, et al., 2001; Lian, et al., 2004). In
direct

immunoassay,

the

emission

of

fluorescent

signals

from

fluorescent

immunonanoparticles eliminated the use of fluorescence-labeled secondary antibody,
meaning a more convenient and less cost method. However, washing efficiency would be
a critical parameter for an accurate direct immunoassay. The incomplete washing would
lead to retention of fluorescent-nanoparticle in biofilms, and as a consequence, false
positive results were observed due to the strong fluorescence emitted from even a single
nanoparticle (Fig. 2.4D).
Detection of L. monocytogenes at the different depths of two-species biofilms
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A microbial biofilm is described as the adherent microorganisms within polymeric
matrix in a single layer or a three-dimensional structure. The antibiotic resistance of
microorganism in biofilms results from the reduced antibiotic penetration in biofilm
matrix (Stewart, et al., 2002). The complex architecture of biofilms has raised concerns
regarding the diffusion ability of antibody-nanoparticle conjugates within biofilms to
reach their target cells at different depths. The optical sectioning of CLSM was used in
this study to examine the detection of L.monocytogenes in the three-dimensional biofilms
by obtaining a series of slices along the z-axis from the top down through the biofilms (zstack imaging). The Z-Stack images for detection of the L. monocytogenes at different
depths of the two-species biofilms (0-3 µm) by both the indirect and direct nanoparticlebased immunoassay (Fig. 2.5) indicated that the conjugation of antibody to nanoparticle
did not impair their diffusion ability inside biofilms. The diffusion of antibodynanoparticle conjugate may be favored by the aqueous channels with sufficient sizes
flowing in between stacks of cells (Smith, 2005).

Conclusions
In this study, we have developed a nanoparticle-based immunoassay for sensitive
detection of L. monocytogenes in biofilms. The use of immunonanoparticles achieved
significant signal amplification for detecting low-abundance targets in two-species
biofilm that are otherwise undetectable with the existing conventional immunoassay. In
addition, the high resolution of this immunonanoparticle-based immunoassay in
combination with CLSM provides a powerful tool for analyzing L. monocytogenes in
different depths of a biofilm. By integrating nanotechnology into complex biological
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systems via such strategy, detection and prevention of L. monocytogenes in biofilms at
the earliest stages of its development might be achievable.
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Figure legends
Fig. 2.1 Typical SEM (a) and confocal (b) images of the DiI-embedded
fluorescent nanoparticles. Also shown are DLS results of the fluorescent nanoparticles (c)
and the blank polymer nanoparticles (d).

Fig. 2.2 Confocal laser scanning microscopy (CSLM) images of GFP-labeled L.
monocytogenes Scott A in 86 h-old mono-species biofilms (A) detected by free anti-L.
monocytogenes (B) and anti-L. monocytogenes-nanoparticle-based indirect assay (C).
(Channel 1: Rhodamine red (excitation: 543 nm; emission: 560 nm longpass); Channel 2:
Green fluorescence protein (excitation: 488 nm; emission: 510-530 nm bandpass);
Channel 3: Combination of channel 1 and 2). Bar = 5 µm.

Fig. 2.3 Fluorescent intensity of L. monocytogenes Scott A in monospecies
biofilms detected by free anti-L. monocytogenes (A) and anti-L. monocytogenesnanoparticles (B).

Fig. 2.4 Confocal laser scanning microscopy (CSLM) images of L.
monocytogenes in two-species biofilm, consisting of GFP-labeled L. monocytogenes
Scott A and P. aeruginosa ATCC 27853, detected by free anti-L. monocytogenes (A),
anti-L. monocytogenes-nanoparticle-based indirect assay (B), anti-L. monocytogenesfluorescent-nanoparticle-based direct assay (C) and 1: 5 diluted anti-L. monocytogenesfluorescent-nanoparticle-based direct assay (D) (Channel 1: Rhodamine red in indirect
assay or DiI in direct assay (excitation: 543 nm; emission: 560 nm longpass); Channel 2:
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Green fluorescence protein (excitation: 488 nm; emission: 510-530 nm bandpass);
Channel 3: Bright field; Channel 4: Combination of channel 1, 2 and 3). Bar = 5 µm.

Fig. 2.5 Confocal laser scanning microscopy (CSLM) z-stack images of L.
monocytogenes at different depths of two-species biofilm, consisting of GFP-labeled L.
monocytogenes Scott A and P. aeruginosa ATCC 27853, detected by anti-L.
monocytogenes-nanoparticle-based indirect assay (A) and anti-L. monocytogenesfluorescent-nanoparticle-based direct assay (B). The images were taken in 1-µm intervals
from the outer surface of the biofilms to the surface of glass slide. Bar = 5 µm.
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CHAPTER THREE
RAPID DETECTION OF LISTERIA MONOCYTOGENES BY NANOPARTICLEBASED IMMUNOMAGNETIC SEPARATION AND REAL-TIME PCR

Abstract
The objective of this study was to develop a method combining nanoparticlebased immunomagnetic separation (IMS) with real-time PCR (RT-PCR) for a rapid and
quantitative detection of Listeria monocytogenes. Carboxyl modified magnetic
nanoparticles were covalently bound with rabbit anti-L. monocytogenes via the amine
groups. The resulting immuno-magnetic nanoparticles (IMNPs) were used in IMS in
order to improve the capture efficiency (CE). Several factors, such as the amount of
IMNPs, reaction and collection time, and washing step, were optimized, and the
nanoparticle-based IMS in combination with RT-PCR was further evaluated for its ability
to detect L. monocytogenes from artificially contaminated milk. The cell numbers
calculated from the means of threshold cycles (CT) were compared to those from plate
counts in order to determine the correspondence degree of quantitative data. CEs by
plating for IMNP-based IMS were 1.4~26 times higher than those of Dynabeads®-based
IMS depending on the initial cell concentrations inoculated into milk samples. When
combined with RT-PCR, IMNP-based method, with a detection limit of 226 CFU/0.5 ml
milk, was ca. 3 log magnitude more sensitive than Dynabeads®-based method. In the
range of 103 to 107 L. monocytogenes CFU/0.5ml, cell numbers calculated from CT values
were 1.5-7 times higher than those derived from plate counts. For Dynabeads®-based
method, the cell numbers calculated from CT values of the two detectable concentrations
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of 106 and 107 CFU/0.5ml were even slight lower than those from plate counts. Due to
their advantages in capturing bacterial cells from milk system and removing
PCR inhibitors, IMNPs may serve as an alternative IMS platform. IMNP-based IMS in
combination with RT-PCR is a promising method for rapid and quantitative detection of
L. monocytogenes from dairy products.

Introduction
Listeriosis

caused

by

ingestion

of

foods

contaminated

with

Listeria

monocytogenes has increased drastically in recent years. Listeriosis is a severe infectious
disease characterized by meningitis, abortion, septicemia, and a high fatality rate (~30%)
(McLauchlin 1996). A range of foods, including milk, cheeses, ice cream, meat and
ready-to-eat (RTE) food, have acted as vehicles in numerous outbreaks of listeriosis
(McLauchlin 1996). The property of Listeria monocytogenes to multiply at refrigeration
temperatures and grow over pH ranges of 4.39 to 9.40 is a particular concern to food
safety (Uyttendaele et al., 1999).
Traditional detection methods for L. monocytogenes often rely on selective
enrichments and subsequent culturing on a selective medium, followed by isolation,
biochemical identification, and sometimes serological confirmation (Donnelly 2002).
These methods are laborious and usually take several days to produce a result. Recently,
the rapid detection of L. monocytogenes in food system by real time-PCR (RT-PCR) has
been reported (Nogva et al., 2000; Hein et al., 2001). Because the threshold cycle (CT) of
RT-PCR is proportional to the copies of initial target genes present in food sample,
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identification and quantification of suspected foodborne pathogen can be completed
simultaneously by RT-PCR. It is commonly accepted that the minimal infectious dose is
at least 100 CFU of L. monocytogenes per g of raw food (Nørrung 2000); however, the
food safety legislations of most countries have strict ‘‘zero tolerance’’ rules for L.
monocytogenes in RTE food (Gallagher et al. 2003). The development of rapid detection
and quantification methods for L. monocytogenes will play an important role in verifying
food safety to prevent listeriosis outbreaks.
The reliability of PCR for pathogen detection partially depends on the purity of
the target DNA template and the presence of sufficient number of target DNA molecules.
Inhibition of PCR by food components, selective enrichment media, or large amounts of
non-target DNA has been previously reported, when Listeria DNA was directly extracted
from food system (Wernars et al. 1991; Rossen et al. 1992; Herman, et al. 1993). For
example, PCR sensitivity of milk samples was much lower than that of pure bacterial
cultures, and some false-negative PCR results were reported, particularly when low
abundant pathogen cells were examined (Romero et al., 1995). Evan at the concentration
of 107 CFU/g, L. monocytogenes was not detected in raw pork meat, and raw or coldsmoked salmon samples due to inhibition of the PCR (Rodríguez-Lázaro et al., 2005).
Immunomagnetic separation (IMS) permits the specific capture of L.
monocytogenes from foods or enrichment broth, so as to concentrate the target cells and
remove inhibitors of the PCR amplification (Fluit et al. 1993; Hudson et al. 2001). Most
of the IMS studies reported so far have been performed using larger magnetic microbeads
(> 1 µm in diameter). Recently, immnonanomaterials, nanomaterials coated with
pathogen specific antibody, have been applied to IMS (Varshney et al. 2005; Lin et al.
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2006). As compared with microbeads-based IMS, the major advantage of using
nanomaterials is the higher capture efficiency due to the high surface-to-volume ratio. A
minimal capture efficiency of 94% for E. coli O157:H7 ranging from 1.6 x 101 to 7.2 x
107 CFU/ml was reported by using magnetic nanoparticle-antibody conjugates (Varshney
et al. 2005). Dr. Sun’s group has conjugated anti-E. coli O157 to carbon magnetic
nanotubes and demonstrated a recovery capability of 40 CFU/0.1 ml in the presence of
Salmonella Typhimurium DT104 cells (Elkin et al., 2005; Lin et al. 2006). Other
advantages of using nanoparticles include faster reaction kinetics and minimal sample
preparation (Varshney et al. 2005).
In this study the magnetic nanoparticles were used to improve the capture
efficiency of IMS of L. monocytogenes cells in comparison to commercially available
anti-Listeria Dynabeads®. The RT-PCR was then applied to the cells captured by
magnetic nanoparticles for a rapid and quantitative assay. The nanoparticle-based IMS in
combination with RT-PCR was further evaluated for its ability to detect pathogenic L.
monocytogenes from artificially contaminated milk.

Materials and Methods
Bacterial culture and growth condition
Listeria monocytogenes Scott A (milk outbreak strain) used in this study was
stored at -80°C. The culture was grown in tryptic soy broth (TSB; Difco, Detroit, Mi)
overnight at 37°C and then washed twice in phosphate-buffered saline (PBS). The cell
concentration was adjusted to about 108 colony forming unit (CFU)/ml, equal to an
optical density (OD) of 0.5 at 600 nm. A serial of 10-fold dilutions in PBS were
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performed and 100 µl of the dilution was spread onto Tryptic Soy Agar (TSA; Difco) for
bacterial enumeration.
Synthesis of magnetic nanoparticles
Iron oxide nanoparticles of 0.3 g, 100 mg 2, 2’-azobis(2-methylbutyronitrile) and
0.12 g hexadecane, as an osmotic agent, were dissolved in 3 g styrene to form the oil
phase; 1.5 g macromonomer 1 and 100 mg SDS were dissolved in 24 ml H2O to form the
aqueous phase. After removing air by using N2, the above two solutions were mixed and
stirred for 1 h. The miniemulsion was prepared by ultrasonicating the emulsion for 10
min at 0 oC in order to prevent polymerization. For polymerization, the temperature was
increased to 65 oC and kept at this temperature for 4 h. A magnetic separator (Dynal
Biotech ASA, Oslo, Norway) was used to harvest the particles containing the iron oxide
nanoparticles.
Preparation of carboxylic acid-functionalized magnetic nanoparticles.
Sodium methoxide was added to a dispersion of magnetic nanoparticles (MNPs)
in water to adjust the pH value to 10 and the resulting suspension was stirred at room
temperature for 8 h. A magnetic separator was used to harvest the carboxylic acidfunctionalized MNPs and washed with water several times. The MNPs were
characterized by transmission electron microscopy for imaging and size measurements
(Fig. 3.1).
Preparation of immuno-magnetic-nanoparticles
Carboxyl modified magnetic nanoparticles were covalently bound with rabbit
anti-L. monocytogenes (Biodesign International, Saco, Me) via the amine groups
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following a protocol described previously by Soukka et al. (2001). Briefly, 100 µl of
nanoparticles were washed with deionized water and then activated in a 1 ml solution of
2% 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (pH 5.6) (SigmaAldrich) for 40 minutes at room temperature. The carbodiimide-activated nanoparticles
were washed with 500 µl of 0.2 M borate buffer and mixed with 4 µg of rabbit anti-L.
monocytogenes in 500 µl of 0.2 M borate buffer (pH 8.5). The mixture was rotated at 30
rpm for overnight at room temperature, and then centrifuged at 14,000 g to remove free
antibody. The pellet was washed and resuspended in 100 µl of wash/storage buffer [0.1
M glycine-saline containing 0.2% NaN3 , 0.05% tween-20 and 0.2% bovine serum
albumin (BSA; Sigma-Aldrich), pH 8.5]. The resulting immuno-magnetic-nanoparticles
(IMNPs), i.e. magnetic nanoparticles coated with anti-L.monocytogenes, were stored at
4 °C. Due to the washing steps of removing unbound antibody, the concentration of antiL. monocytogenes coated on 100 µl of IMNPs was less than 4 µg/100 µl.
Immunomagnetic separation by IMNPs and anti-Listeria Dynabeads®
Five hundred microliter of L. monocytogenes suspension from each serial dilution
was mixed with 12 µl of IMNPs. The mixture was rotated at 30 rpm for 15, 30 or 60 min
at room temperature. The IMNPs were collected by magnetic separator for 1 h and
resuspended in 200 µl of PBS with or without the wash of PBS buffer. One hundred
microliter of cell suspension was surface-plated onto TSA after appropriate dilution and
incubated for 24–48 h at 37°C. Another 100 µl of cell suspension was used for DNA
extraction. The experiment was performed in duplicate.
As a control, anti-Listeria Dynabeads® (Dynal Biotech ASA, Oslo, Norway),
approximately 2.8 µm in diameter, were used in parallel with IMNP-based assays

93
following the instructions of the manufacturer. The concentrated bacteria-bead complexes
were immediately subjected to plating and DNA extraction.
Specificity of IMNP-based IMS
Serial dilutions of L. monocytogenes cells from 102 to 104 CFU/0.5 ml were
mixed with Escherichia coli ATCC 25922 at a ratio of 1:100. The bacterial enumeration
was performed on Oxford plates (Difco) and PCR detection was prepared as described
below.
Real-time PCR
Total bacterial DNA of cells captured by IMNPs or Dynabeads® was extracted by
boiling method. L. monocytogenes specific primers (5′-TGCAAGTCCTAAGACGCCA3′ and 5′-CACTGCATCTCCGTGGTATACTAA-3′) were used to amplify a 113-base
pair fragment of the listeriolysin O gene (hlyA) as described by Nogva et al (2000). PCR
reaction was carried out in a total volume of 25 µl containing 4 µl of bacterial DNA, 12.5
µl of iQ™ SYBR Green supermix (Bio-Rad, Hercules, CA), and 2 µl of primer sets (25
µM). The amplification profile was as following: 95 °C for 10 min, 40 cycles of 95°C for
20 s and 60°C for 1 min and a final extension at 72 °C for 5 min. Both real-time PCR
reaction and data analysis were performed in the iCycler (Bio-Rad, Hercules, CA). The
specificity of amplicons was verified by the specific melting temperature of a melting
curve produced after each PCR reaction. All runs included a negative reagent control and
positive control of pure DNA of L. monocytogenes.
To construct the standard curve, DNA isolated from ten-fold serial dilutions of
pure L. monocytogenes Scott A ranging from 2 to 2 × 106 CFU/PCR reaction was
amplified in duplicate by real-time PCR. Cell numbers per PCR reaction of unknown
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samples were obtained by comparing CT values with standard curve generated during the
same run of PCR. A standard curve was included each time when new batch of samples
was tested. The cell numbers per 0.1 ml of unknown samples were calculated by
multiplying the cell numbers per PCR with a factor of 25, as 4 µl DNA out of 0.1 ml of
each sample was used in a PCR reaction. As described above, 0.5 ml of cell suspension
was concentrated to 0.2 ml among which 0.1 ml was used for DNA extraction. Thus the
cell numbers per 0.1 ml was further multiplied by 2 to estimate the original cell numbers
present in 0.5 ml of cell suspension.
Detection of L. monocytogenes in artificially contaminated milk
Fresh milk (2.0% reduced fat) was purchased from a local grocery store and tested
as negative for the L. monocytogenes by both selective plating and PCR methods before
use. Overnight culture of L. monocytogenes Scott A was ten-fold serially diluted in PBS
as described above. One hundred µl of this dilution was added to 900 µl of milk. Five
hundred µl of the artificially contaminated milk sample was mixed with 12 µl of IMNPs.
After IMS, the concentrated cells were subjected to both plating and RT-PCR as
described above. The CE was calculated in the same way as those described for L.
monocytogenes Scott A in PBS buffer. CEs calculated from the mean CT values were
compared to those from conventional plating method in order to determine the
correspondence degree of quantitative data.
Capture effiency calculations and statistical analysis
Capture efficiency (CE) is defined as the percentage of the total bacteria retained
on the surface of the immunoparticles (Varshney et al., 2005). The calculation of CE was
based on cells bound to immunoparticles:
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CE (%) = (Cb / Co) x 100%.
Where Co is the total cell numbers present in samples (CFU/0.5 ml), Cb is the
estimated cell numbers bound to immunoparticles by either plating or RT-PCR method
(CFU/0.5 ml). Specific comparisons of CEs between different amounts of IMNP used,
different reaction and collection times, wash once and no wash were performed with
Fisher’s least significant difference (LSD) test of the Statistical Analysis System (SAS
2001, Cary, Nc).

Results
Optimizing immunomagnetic separation using IMNPs
Amount of IMNPs, reaction time and collection time are critical for effective
binding between IMNPs and target L. monocytogenes, and separation of target cells from
the background. Preliminary experiments were performed to optimize these factors for an
efficient cell capture. The effect of IMNP volume on cell capture efficiency and RT-PCR
detection limit was tested across a range of L. monocytogenes concentrations (Table 3.1).
Significantly (P < 0.05) lower CEs in the use of 6 µl IMNPs than those of 12 and 25 µl of
IMNPs were observed (Table 3.1). In combination with RT-PCR, the use of 50 and 6 µl
of IMNPs resulted in a ten-time higher detection limit than 25 and 12 µl of IMNPs. To
minimize the use of IMNPs, 12 µl of IMNPs was chosen for all the following
experiments.
Reaction time of 15, 30 and 60 min was applied to the cell suspension of 103
CFU/0.5 ml, separately. As shown in Figure 3.2A, the CE for 15 min was more than 60%;
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however, further increase of reaction time to 30 and 60 min did not improve CE
significantly (P > 0.05). On the contrary, increase of collection time from 15 to 60 min
significantly (P < 0.001) increased CE from 12.1% to 58.4% (Fig. 3.2B). In order to
reduce the total processing time, both 15 min and 60 min were chosen as reaction time
and collection time, respectively, for all the following experiments.
L. monocytogenes Scott A and E. coli ATCC 25922 were mixed at a ratio of
1:100, and were used to evaluate the specificity of IMNP-based IMS. Washing once with
PBS buffer and no wash were compared by both plating and RT-PCR methods across
L.monocytogenes concentrations from 103 to 105 CFU/0.5ml. Table 3.2 revealed no
significant differences (P > 0.05) between CEs with and without wash step, indicating
nanoparticle-based IMS was specific enough to remove background bacteria even
without the wash step. Since wash once took another 1 hour for collecting IMNPs, no
wash after IMS was used for for all the following experiments.
Detection of L. monocytogenes in PBS and artificially contaminated milk
RT-PCR

assay

was

validated

by

detecting

known

concentrations

of

L.monocytogenes in PBS buffer. The standard curve was constructed by plotting the CT
values against the log cell numbers ranging from 2 to 2 × 106 cells/PCR reaction (Fig.
3.3A). The slope obtained from the standard curves was -3.344, indicating a PCR
efficiency of 99.1 %. The squared correlation coefficient (r2) was 0.988 from the standard
curve. As few as two L. monocytogenes cells/PCR reaction were detected by our RT-PCR
method; the negative control without cells did not increase in fluorescence above
background levels (data not shown).
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The applicability of IMNP-based IMS plus RT-PCR to quantify L.
monocytogenes in milk was assessed. The background bacteria present in milk purchased
from grocery store were less than 100 CFU/ml. When DNA was directly extracted from
the milk samples, there was no RT-PCR amplification even at the concentration of 107
CFU L. monocytogenes/ml (Fig. 3.3B).
Two different pre-PCR treatments, i.e. IMNP-based and Dynabeads®-based IMS,
were compared for detecting L. monocytogenes artificially inoculated to milk samples at
102 to 107 CFU/0.5 ml (Fig. 3.4). CEs by plating method were less than 1.79% for
Dynabeads®-based IMS, but were in the ranges of 1.92~6.64% for IMNP-based IMS
(Table 3.3). As compared with Dynabeads®-based IMS, IMNP-based IMS recovered
about 1.4~26 times more cells depending on the cell concentrations in milk.
For Dynabeads®-based IMS in combination with RT-PCR, two L. monocytogenes
concentrations, i.e. 106 and 107 CFU/0.5 ml, were amplified successfully (Fig. 3.4A).
Amplification of L. monocytogenes at the concentration of 105 CFU/0.5 ml was only
achieved in one out of the four replicates. Dynabeads®-based IMS in combination with
could not detect any L. monocytogenes if cell populations were less than 105 CFU/0.5 ml
in milk. As a comparison, RT-PCR amplification was observed for cell populations
across the range of 102 to 107 CFU/0.5ml when IMNP-based IMS was combined with
RT-PCR (Fig. 3.4B). Apparently, IMNP-based IMS in combination with PCR was ca. 3
log magnitude more sensitive than Dynabeads®-based IMS in combination with PCR.
For the two concentrations (106 and 107 L. monocytogenes CFU/0.5 ml) detected
by Dynabeads®-based IMS in combination with RT-PCR, cell numbers derived from CT
values were even lower than those obtained from plate counts (Table 3.3). On contrary,
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for IMNP-based IMS in combination with RT-PCR, cell numbers calculated from the
mean CT values were ca. 1.5-7 times higher than those derived from plate counting (Table
3.3). When initial target pathogen concentrations were lower, e.g. 102 to 103 CFU/0.5ml,
IMNP-based RT-PCR was highly sensitive with CEs of 27.4 and 100%, respectively.

Discussion
Due to the presence of PCR inhibitors, the detection of DNA extracted directly
from dairy products by PCR was less sensitive than DNA extracted from pure bacterial
culture (Bickley et al. 1996; Romero et al. 1995). Both chemical extraction, such as
phenol–chloroform procedure, and IMS have been used for purifying bacterial DNA from
milk for PCR (Nogva et al. 2000; Hein et al. 2001; Choi and Hong 2003; Amagliani et al.
2004; Amagliani et al. 2006). IMS provides DNA suitable for PCR without the use of
toxic reagents and organic solvents (Herman 2003). In this study, immuno-magneticnanoparticles (IMNPs), magnetic nanoparticles covalently coated with anti-L.
monocytogenes, were used in IMS in order to improve the capture efficiency. The
optimized IMNP-based IMS was applied to concentrate target L.monocytogenes cells
from milk and provide the DNA with less-inhibitor for a rapid and quantitative RT-PCR.
The results of present study revealed the advantages of magnetic nanoparticles
over microbeads in capturing L. monocytogenes (Table 3.3). Similar advantages of using
magnetic nanoparticles in separating E. coli O157:H7 cells had been reported previously
(Vashney et al., 2005). The unique property of high surface-to-volume ratio of
nanomaterials is a well-accepted mechanism conttributing to the higher capture efficiency
(Vashney et al., 2005; Lin et al., 2006). The small size of the magnetic nanoparticles
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facilitates the rapid binding kinetics to target cells, especially in viscous food matrix.
Vashney et al (2005) reported that no mixing was required during the IMS of E.coli
O157:H7 from ground beef since magnetic nanoparticles had efficient diffusion
properties. Milk samples contain various components, such as fat globules, protein
(casein) and lactose. Clearly, nanoparticles could diffuse well in milk where larger
particles, such as Dynalbead®, would be impaired by those milk particles.
The better capture efficiencies displayed by IMNPs over Dynabeads® could also
be explained by the quality of antibody used. Anti-L. monocytogenes used for coating
MNP in this study was more specific for L. monocytogenes antigen than anti-Listeria on
Dynabeads®. The anti-Listeria precoated on Dynabeads® specifically recognized flagellar
antigens on all Listeria spp. cells. The production of flagella L. monocytogenes is
dependent on the incubation temperature, and the maximum expression occurs at 30 ºC
(Skjerve et al., 1990). However, the officially recommended temperature for L.
monocytogenes enrichment is 37 ºC due to its higher growth rate than at 30 ºC (Silk et al.
2002). The used of anti-L. monocytogenes in this study is independent of incubation
temperature, therefore, more antigens will be avaiable when the bacteria are cultured at
37 vs. 30ºC. Moreover, the fact that flagella may break off easily during IMS may reduce
the CE of Dynabeads® (Fluit et al., 1993).
To our knowledge, this is the first report of combining IMNP-based IMS with
RT-PCR for a quantitative detection of L. monocytogenes from milk. The volume of
IMNP used for IMS was found to be critical to the detection limit and quantification by
RT-PCR. The optimized volume of IMNP should yield high numbers of purified target
bacteria, but should not reduce the DNA extraction efficiency. After IMS, the entire
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surfaces of captured bacterial cells were covered by IMNPs due to their smaller sizes
compared to bacterial cells (Zhao et al. 2004). An excessive quantity of nanoparticles
present on the cell surface is desirable for cell separation but likely to affect the DNA
extraction efficiency and therefore the detection limit. From this study, both 12 and 25 µl
of IMNPs yielded similar capture efficiencies and detection limits. However, the use of
50 µl of IMNPs was too much for an efficient DNA extraction and 6 µl of IMNPs was
too less for an efficient cell recovery. As a consequence, the later two concentrations
resulted in higher detection limits.
The relative accuracy, i.e., the closeness of agreement between the detected cell
numbers and the actually inoculated cell numbers, is a critical parameter for evaluating a
quantitative detection method. Cell numbers derived from IMNP-based RT-PCR were
more than 25 times closer to the actual cell numbers present in milk samples than those
from Dynabeads® based RT-PCR (Table 3.3). Accurate quantification by RT-PCR
depends on both efficient DNA extraction and removal of PCR inhibitors. The volume of
IMNP used was optimized for a maximum cell recovery and DNA extraction. The closer
agreement resulted from IMNP-based in combination with RT-PCR demonstrated the
advantage of IMNPs over Dynabeads® in removing PCR inhibitors of food origin. Our
results also revealed that IMNP-based IMS is specific enough to purify the target cells
from complex samples even without the wash step (Table 3.2). The wash step could be
avoided for saving time and minimizing cell losses.
When IMNP-based IMS was applied to artificially contaminated milk samples,
cell numbers calculated from RT-PCR resulted in 1.4~7.4 times higher than those from
plating method. The retention of MNP-bacteria complex in hydrophobic polystyrene
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eppendorf tubes may reduce CFU counts, since hydrophobic interaction is the most likely
mechanism involved in adsorption of proteins. Siliconized eppendorf tubes which are
hydrophilic were used in this study in order to minimize the retention of bacteria cells in
tubes. Aggregation of E. coli O157: H7 in the presence of nanoparticles have been
reported previously (Qu et al., 2005; Varshney et al., 2005). In the case of aggregation,
one cell colony is not necessarily derived from one single bacterial cell. Thus the CE
derived from the plate counts could be underestimated. On the other hand, PCR detects
the total DNA of microorganisms no matter if they are alive or not. L. monocytogenes
cells which are alive but not culturable after IMS are also a likely explanation for the
observed discrepancy between plating and RT-PCR methods.
Our IMNP-based IMS in combination with RT-PCR obtained a sensitivity of 3.4
CFU per PCR reaction corresponding to 226 CFU/0.5 ml from milk. In theory, PCR can
detect one copy of DNA gene if the prepared DNA is inhibitor free and the amplification
conditions are optimized. Thus the detection limit depends on the capability of pre-PCR
treatments to concentrate target cells from food samples to a desirable level for a
successful PCR amplification. More sensitive detection could be achieved by
concentrating bacterial cells from a larger volume of food samples, e.g. centrifugation.
Amaglizni et al (2006) reported a detection limit of 10 CFU/ml with the help of
centrifugation to recover L. monocytogenes cells from 10 ml milk samples. In their study,
nanoparticles modified with oligonucleotide specific to hlyA gene were used to capture L.
monocytogenes DNA extracted from milk pellet. Since the nanoparticle-DNA hybrids
were applied to PCR, the PCR efficiency was reduced by the presence of magnetic
nanoparticles in a dose-dependent manner. As a comparison, the use of IMNPs in this

102
study avoided the introduction of magnetic nanoparticles into PCR reaction, as the
IMNPs were removed by centrifugation after DNA extraction.
Many protocols require testing absence of L. monocytogenes in 25 g or 25 ml
food sample. In the nanoparticle-based DNA hybridization, increase of milk volume from
10 ml to 25 ml did not result in an improved sensitivity because of the concentrated PCR
inhibitors from 25 ml milk samples (Amaglizni et al. 2006). In stead of batch mode of
operation, microbeads-based continuous-flow IMS has the potential to collect a single
bacterial cell out of 25 ml food samples (Chandler et al., 2001). Due to the demonstrated
higher CEs and ability of removing PCR inhibitors by using IMNPs in this study, the
application of IMNPs in an appropriate IMS format plus RT-PCR will achieve the longterm goal of rapid single bacterial cell detection in food products.

Conclusions
To our knowledge, this is the first report of combining IMNP-based IMS with
RT-PCR for a quantitative detection of L. monocytogenes in artificially contaminated
milk. As compared by conventional plating method, the CEs of IMNP-based IMS were
1.4~26 times higher than those of Dynabeads®-based IMS depending on the initially
inoculated cell concentrations. When combined with RT-PCR, IMNP-based method was
ca. 3 log magnitude more sensitive than Dynabeads®-based method. A good correlation
between cell numbers and CT values was observed in the range of 103 to 107 CFU L.
monocytogenes /0.5ml milk. IMNPs may serve as an alternative IMS platform due to the
superiority over microbead-based techniques in capturing cells from milk system and
providing DNA with less inhibitors o RT-PCR. IMNP-based IMS combined with RT-
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PCR could be a promising method for rapid, ca. 6 h of analysis time, and quantitative
detection of L. monocytogenes from dairy products.
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Figure legends
Fig. 3.1 Typical TEM image of magnetic nanoparticles and dynamic light
scattering result of magnetic nanoparticles in an aqueous suspension.
Fig. 3.2 Capture efficiency of immnuno-magnetic-nanoparticles against 103
CFU/0.5 ml of L. monocytogenes with 15, 30 and 60 min of immunoreaction time (2A);
with 15, 30 and 60 min of collection time (2B). Values were the means of three trials.
Means with the same letter are not significantly different at the 5% probability level.
Fig. 3.3 Standard curve generated by RT-PCR amplification of serial dilutions of
L. monocytogenes in PBS (A) and direct RT-PCR detection of L. monocytogenes at
concentration of 106 (

) and 107 ( ) CFU/0.5 ml in artificially contaminated milk (B).

Fig. 3.4 RT-PCR detection of L. monocytogenes at concentration of 102 ( ), 103
( ), 104 (

), 105 ( ), 106 ( ) and 107 ( ) CFU/0.5 ml in artificially contaminated milk

after Dynabeads® -based IMS (A) and immnuno-magnetic-nanoparticles-based IMS (B).
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CHAPER FOUR
ENHANCING ANTIMICROBIAL ACTIVITY OF LYSOZYME AGAINST LISTERIA
MONOCYTOGENES USING IMMUNONANOPARTICLES

Abstract
The antibacterial efficacy of lysozyme may be reduced by the undesirable
interactions with food components and non-target bacteria. Immunonanoparticles,
nanoparticles functionalized with pathogen-specific antibodies, may serve as an
antimicrobial carrier for improving the stability and activity of antimicrobials in foods.
The objective of this research was to study the antimicrobial activity of lysozymecarrying immunonanoparticles against Listeria monocytogenes. Polystyrene nanoparticles
with active carboxyl groups were conjugated with anti-L. monocytogenes through
covalent

bounding.

Enhanced

antibacterial

activity

of

lysozyme-carrying

immunonanoparticles was achieved when anti-L. monocytogenes at the concentration of
0.04 µg/ml was used for coating nanoparticles and the resulting immunonanoparticles
were coated with lysozyme for 6 h. With a final concentration of 35 µg lysozyme/ml,
lysozyme-carrying immunonanoparticles reduced L. monocytogenes Scott A population
from ca. 5 log10 CFU/ml to below the detection limit (< 1 log10 CFU/ml) within 3 h.
However, when 500 µg/ml lysozyme solution was used, ca. 2 log10 CFU/ml of L.
monocytogenes cells remained culturable after 5 h treatment. The addition of lysozymecarrying immunonanoparticles (37 µg lysozyme/ml) to L. monocytogenes solution of ca.
7 log10 CFU/ml resulted in 0.9, 1.0 and 2.3 log more of L. monocytogenes cells reduction
than

lysozyme-carrying

nanoparticles

and

lysozyme

solutions

of

500
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and 50 µg/ml, respectively. Overall, lysozyme-carrying immunonanoparticles exerted
significantly (P < 0.05) higher anti-L. monocytogenes activities than lysozyme-carrying
nanoparticles, lysozyme solution at higher concentrations (50 and 500 µg/ml). Our study
revealed that the use of lysozyme-carrying immunonanoparticles is a more effective
method than direct addition of lysozyme to inactivate L. monocytogenes.

Introduction
Listeria monocytogenes is a gram-positive pathogen frequently involved in
outbreaks of food-borne disease. A number of methods have been employed to control or
prevent it in foods. The use of natural antimicrobials as food preservatives is a
widespread trend in food industry to meet the demand of “natural” food products by
consumers. Lysozyme, naturally present in foods, such as egg white, is generally
recognized as safe (GRAS) for use as a food additive in many countries (Proctor and
Cunningham, 1988). Its antimicrobial properties come from the mechanisms based on
hydrolysis of peptidoglycan layers in cell wall, membrane perturbation (Masschalck et
al., 2002) and the induction of autolysins (Ibrahim et al., 2001). It is active against most
Gram positive bacteria, but less effective against Gram negative bacteria because of the
protection of outer membrane. The natural and inexpensive qualities of lysozyme make it
suitable for food applications. Commercially, lysozyme has been used primarily in semihard cheeses to prevent Clostridium tyrobutyricum (Bester and Lombard, 1990). The
potential use of lysozyme as a food preservative to control L. monocytogenes (Hughey et
al., 1989; Were et al., 2004, Branen and Davidson, 2004), meat spoilage bacteria
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(Nattress et al., 2001) and lactic acid bacteria (Chung and Hancock, 2000) has been
studied.
Direct introduction is currently the most popular method used for application of
antimicrobials to food products. The undesirable interaction of antimicrobial compounds
with various food components and with a large population of non-target bacteria reduces
their efficacy against pathogens. The fact that lysozyme alone is effective only at very
high concentrations limits its application in foods (Liberti et al., 1996). Therefore, there is
a need for developing alternative antimicrobial delivering strategies that enhance
antimicrobial stability and activity in food systems.
Nanoparticles possess the high drug-loading capacities due to their high surface-to
volume ratio, and protect the incorporated drugs against degradation. Enhanced activity
of antimicrobial-loaded nanoparticles against pathogenic bacteria has been reported in the
literatures. For example, compared with applying three doses of 32 mg each of ampicillin
to treat experimental salmonellosis in mice, a similar curative effect was achieved by a
single injection of 0.8 mg of nanoparticle-bound ampicillin (Fattal et al., 1989).
Antimicrobial activity of ciprofloxacin-loaded poly-nanoparticles against Pseudomonas
aeruginosa and Staphylococcus aureus was comparable with an equally concentrated
ciprofloxacin solution, but with prolonged release (Dillen et al., 2006).
Lian et al. (2004) reported that immuno-nanoparticles, which gather hundreds of
antibodies on their surfaces, could dramatically increase the recognition and interaction
between antigen and antibody. Due to highly specific recognition, immunonanoparticles
displayed an 8-fold higher binding affinity toward antigen than free antibody (Soukka et
al., 2001). Immunonanoparticles enable the delivery of antimicrobials directly to target
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cells. Therefore, immunonanoparticle may serve as an antimicrobial carrier with the
combined advantage of targeted antimicrobial delivery and improved stability of
antimicrobials on nanoparticles. The objectives of this research were to optimize
experimental conditions to produce lysozyme-carrying immunonanoparticles, and study
the antimicrobial activity of lysozyme-carrying immunonanoparticles against L.
monocytogenes in peptone water.

Materials and methods
Culture preparation
L. monocytogenes Scott A used in this study was stored at -80°C. Before each
experiment, L. monocytogenes Scott A was initially grown on Tryptic Soy Agar (TSA;
Difco Laboratories, Detroit, Mi) overnight at 37 °C. A single colony was picked up and
inoculated in Tryptic Soy Broth (TSB; Difco Laboratories) at 37 °C for 20 h.
Preparation of immunonanopartilces
Carboxyl modified nanoparticles, synthesized in Dr. Sun’s lab (Clemson
University), were covalently bound with rabbit anti-L. monocytogenes (Biodesign
International, Me) via the amine groups following a protocol described previously by
Soukka et al. (2001). Briefly, 100 µl of nanoparticles were washed with deionized water
and then activated in a 1 ml solution of 2% 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide hydrochloride (pH 5.6) (Sigma, St. Louis, Mo) for 40 minutes at room
temperature. The carbodiimide-activated nanoparticles were washed with 500 µl of 0.2 M
borate buffer and mixed with rabbit anti-L. monocytogenes of concentrations in the range
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of 0.04 to 40 µg/ml in 500 µl of 0.2 M borate buffer (pH 8.5). The mixture was rotated at
30 rpm for overnight at room temperature, and then centrifuged at 14,000 g to remove
free antibody. The resulting immunonanoparticles, nanoparticles coated with anti-L.
monocytogenes, were stored in 100 µl of wash/storage buffer [0.1 M glycine-saline
containing 0.2% NaN3 , 0.05% tween-20 and 0.2% bovine serum albumin (BSA; Sigma),
pH 8.5] at 4 °C.
Preparation of lysozyme-carrying immunonanoparticles and lysozyme-carrying
nanoparticles
Lysozyme stock solution (5 mg/ml) was prepared by dissolving the lysozyme
powder (47, 000 units/mg, Sigma) from chicken egg white, in sterile water. One hundred
microliter of nanoparticles and immunonanoparticles were centrifuged and resuspended
in 100 µl of lysozyme solution (5 mg/ml). After rotation at 30 rpm at room temperature
for 2, 4, 6, 12 and 20 h, respectively, the lysozyme-carrying nanoparticles and lysozymecarrying immunonanoparticles were collected in a centrifuge at 14, 000 g for 10 min.
Unabsorbed lysozyme in supernatant was removed, and pellet was washed and
resuspended in 100 µl of wash/storage buffer.
Determination of lysozyme concentrations on nanoparticles
Lysozyme concentrations on nanoparticles and immunonanoparticles were
determined by a total protein kit, micro Lowry (Sigma), following the instructions of the
manufacturer. This method is based on Peterson's modification of the micro-Lowry
method. Immunonanoparticles and nanoparticles were used as blanks for lysozymecarrying imunonanoparticles and lysozyme-carrying nanoparticles, respectively.
Lysozyme treatment on L. monocytogenes
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Overnight culture of L. monocytogenes Scott A was washed and diluted with 0.1%
peptone water. Aliquots of serial dilutions were plated on TSA plates to enumerate the
initial populations. Nine hundred microliter of inoculum in duplicate was then added to
each of sterile eppendorf tube containing 100 µl of lysozyme solution, nanoparticles,
immunonanoparticles,

lysozyme-carrying

nanoparticles

or

lysozyme-carring

immunonanoparticle. Each tube was rotated at room temperature at 30 rpm. At selected
intervals, the L. monocytogenes Scott A populations were enumerated by spread plating
onto TSA plates. The plates were incubated at 37 °C for 24 h. Each experiment was
replicated three times.
Statistical analysis
Bacterial counts were concerted to log10 CFU/ml for statistical analysis. Specific
comparisons between any pair of treatment means at any time were performed with
Fisher’s least significant difference (LSD) test of the Statistical Analysis System (SAS
2001, Cary, Nc)

Results and Discussion
The efficacy of lysozyme, on its own, as a food preservative is relatively low.
Liberti et al. (1996) demonstrated that lysozyme (50, 000 IU/mg) at the concentration of
20 µg/ml decreased the number of L. monocytogenes Scott A cells from 8.84 to 7.38 log10
CFU/ml after 3 h and to 5.0 log10 CFU/ml after 24 h. The minimal inhibitory
concentrations (MIC) for lysozyme (70,000 IU/mg) against 104 CFU L. monocytogenes
Scott A/ml was 250 µg/ml (Branen and Davidson, 2004). As a consequence, lysozyme is
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usually used in combination with either nisin or EDTA to achieve a more efficient
inhibition attributed to synergistic effect (Chung and Hancock, 2000; Nattress et al 2001;
Branen and Davidson, 2004). In order to enhance its antibacterial activity, the use of
immunonanoparticle as a carrier for lysozyme was evaluated in this study.
The immunonanoparticles coated with lysozyme solution (5 mg/ml) for various
hours were tested for their antibacterial activity (Fig. 4.1). As controls, L. monocytogenes
in 0.1% peptone water grew about 1 log10 CFU/ml and remained the same population at
the presence of immunonanoparticles with 6 h. The application of lysozyme-carrying
immunonanoparticles resulted in ca. 2 log instantaneous reduction of L. monocytogenes
populations, which was significantly different (P < 0.05) from the ca. 1 log reduction by
lysozyme solution of 500 µg/ml (Table 4.1). Immunonanoparticles coated with lysozyme
for > 6 h reduced L. monocytogenes population from 5.1 log to below the detection limit
(< 1 log10 CFU/ml) within 3 h. Immunonanoparticles coated with lysozyme for 2 h or 4 h
achieved the same reduction of L. monocytogenes within 6 h of incubation. However,
lysozyme solution (500 µg/ml) resulted in a population reduction from 5.1 log to 2.3 log
in 6 h. The reduction of L. monocytogenes populations by lysozyme-carrying
immunonanoparticles was significantly (P < 0.05) higher than by 500 µg/ml lysozyme
solution (Table 4.1). These results clearly demonstrated the enhanced activity of the
lysozyme-carrying immunonanoparticles against L. monocytogenes.
The concentration of lysozyme adsorbed on the immunonanoparticles was
determined using a modified Lowry method. The standard curve produced for this assay
had a correlation coefficient of 0.99 (data not shown). Immunonanoparticles coated with
5 mg/ml lysozyme solution for 6 h were found to have a final lysozyme concentration of
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0.353 mg/ml. Since 100 µl of lysozyme-carrying immunonanoparticles was added to 900
µl of L. monocytogenes solution, the final concentration of lysozyme-carrying
immunonanoparticles used for treating L. monocytogenes was about 35 µg/ml. There was
no significant (P > 0.05) difference in L. monocytogenes inactivation observed among the
immunonanoparticles coated with lysozyme for 6, 12 and 20 h (Table 4.1). Since the
antibacterial activity of immunonanoparticles coated with lysozyme for 6 h was
significantly (P < 0.05) higher than that of immunonanoparticles coated with lysozyme
for 2 and 4 h after 3 h treatment of L. monocytogenes (Table 4.1), immunonanoparticles
were coated with lysozyme for 6 h for all further tests. The final concentration of
lysozyme on immunonanoparticles was determined for each treatment.
Figure

4.2

compared

the

antibacterial

activity

of

lysozyme-carrying

immunonanoparticles (35 µg lysozyme/ml) coated with various concentrations of anti-L.
monocytogenes. All lysozyme-carrying immunonanoparticles reduced L. monocytogenes
population from 5.1 log to below the detection limit within 3 h, whereas lysozyme
solution (500 µg/ml) resulted in a reduction to 2.2 log in 5 h. Immunonanoparticles
covalently bound with 0.04 µg/ml anti-L. monocytogenes was found to result in the same
(P > 0.05) level of inhibition as higher antibody concentrations up to 40 µg/ml (Table
4.2). The use of 0.04 µg/ml anti-L. monocytogens, the lowest concentration evaluated, for
coating nanoparticles achieved a significantly (P < 0.05) higher antibacterial activity than
the use of 500 µg/ml lysozyme solution (Table 4.2).
The antibacterial effectiveness of lysozyme-carrying immunonanoparticles and
lysozyme-carrying nanoparticles against L. momocytogenes at higher concentration of 107
CFU/ml was further assessed in comparison with lysozyme solutions of 50 and 500
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µg/ml (Fig. 4.3). The anti-L. momocytogenes concentration used for coating both
lysozyme-carrying immunonanoparticles and immunonanoparticles was 0.04 µg/ml, and
the final lysozyme concentration of both lysozyme-carrying immunonanoparticles and
lysozyme-carrying nanoparticles was 37 µg/ml. Lysozyme-carrying nanoparticles (37 µg
lysozyme/ml) yielded an extra 1.4 log reduction as compared with 50 µg/ml lysozyme
solution at 6 h (Fig. 4.3). Lysozyme-carrying nanoparticles displayed significantly (P <
0.05) higher antibacterial activity than 50 µg/ml lysozyme solution through all the
treatment time tested (Table 4.3). On the other hand, lysozyme-carrying nanoparticles (37
µg lysozyme/ml) had comparable (P > 0.05) anti-L. momocytogenes activity as 500 µg/ml
lysozyme solution did. The enhanced antibacterial activity of lysozyme-carrying
nanoparticles over 50 µg/ml lysozyme solution may be explained by the enhanced
stability and highly localized concentration of lysozyme on nanoparticles. The release
kinetics of antimicrobial from nanoparticles may also provide the explanation for the
enhanced activity of lysozyme on nanoparticles. It has been known that the release of
antimicrobial from nanoparticles would follow a steady release rate so that the
antimicrobial levels remain constant to achieve a more effective cell kill (Landgraf et al.,
2003).
The addition of lysozyme-carrying immunonanoparticles reduced 2.3 log more of L.
monocytogenes cells than 50 µg/ml lysozyme solution and 1 log more than 500 µg/ml
lysozyme solution in 6 h (Fig. 4.3). The anti-L. momocytogenes activity of various
treatments from the highest to lowest followed the following order: lysozyme-carrying
immunonanoparticles > lysozyme-carrying nanoparticles ≥ lysozyme solution of 500
µg/ml

>

lysozyme

solution

of

50

µg/ml.

Apparently,

lysozyme-carrying
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immunonanoparticles exerted significantly (P < 0.05) higher anti-L. momocytogenes
activity than lysozyme solutions at even higher concentrations (50 and 500 µg/ml).
As compared with more than 4 log reduction presented in Table 4.2, a slower
reduction (3.5 log) of L. momocytogenes with lysozyme-carrying immunonanoparticles
was observed in Table 4.3. This may be explained by the higher L. momocytogenes
populations (107 CFU/ml) used in Table 4.3. With the same amount of lysozyme coated
on immunonanoparticles the inactivation of higher L. momocytogenes populations may
require longer treating time than lower L. momocytogenes populations.
The incorporation of immunonanoparticles for antimicrobial delivery was more
effective for pathogen inactivation than the increase of lysozyme concentrations or the
use of plain nanoparticles. The primary antibacterial activity of lysozyme comes from the
hydrolysis of the polysaccharide bonds between peptidoglycan layers in cell wall (Proctor
and Cunningham, 1988); however, the detailed mechanism of the enhanced antibacterial
effect of lysozyme-carrying immunonanoparticles has not been determined yet. It may be
explained by the synergistic effect of using nanoparticles, anti-L. monocytogenes and
lysozyme. Lysozyme carried on immunonanoparticles could be directly delivered to the
target cells because of the high binding affinity between the immunonanoparticles and
corresponding antigens (Soukka et al., 2001; Lian et al., 2004). Strong antibody-antigen
reaction leads to the direct surface contact between lysozyme carried on
immunonanoparticles and L. monocytogenes cells. This close contact allows lysozyme
being released from immunonanoparticles to achieve a higher concentration around L.
monocytogenes cells for an efficient intracellular delivery. Direct delivery of lysyzyme to
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target cells avoided the undesirable interactions with food components and as a
consequence, the addition of large quantities is not necessary.
Materials such as liposomes and polyvinylalcohol films have been studied as
lysozyme carriers for enhancing antimicrobial stability (Were et al. 2003; Conte et al.
2006). However, a major concern for practical application is the reduction in
antimicrobial activity after immobilization. Were et al. (2004) reported that although
encapsulated nisin was more effective at inhibiting L. monocytogenes than free nisin,
encapsulated lysozyme was less effective than free lysozyme against L. monocytogenes.
In this study, the enhanced activity of lysozyme-carrying immunonanoparticles against L.
monocytogenes suggests that the use of immunonanoparticles is a more effective method
in improving antimicrobial stability and activity.

Conclusions
Lysozyme-carrying immunonanoparticles, covalently bound with 0.04 µg/ml anti-L.
monocytogenes and with a final concentration of 35 µg lysozyme/ml, demonstrated
enhanced activity against L. monocytogenes over lysozyme solutions at higher
concentrations (50 and 500 µg/ml). Enhanced activity was also observed for lysozymecarrying nanoparticles; however, a greater extent of enhancement has been achieved by
lysozyme-carrying immunonanoparticles due to the synergistic effect of using
nanoparticles, anti-L. monocytogenes and lysozyme. Further investigations need to be
performed for elucidating the mechanism of this synergistic antibacterial effect. In
conclusion, our study reported the development of immunonanoparticles-mediated novel
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antimicrobial delivery strategy, which has some potential for targeted-pathogen
reductions in food or animal applications.
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Figure legends
Fig. 4.1 Reduction of L. monocytogenes Scott A (105 CFU/ml) by
immunonanoparticles coated with 5 mg/ml lysozyme for 2 ( ), 4 (
and 20 h (

), lysozyme solution (500 µg/ml) (

peptone control (

), 6 (

), 12 (

), immunonanoparticles (

)

) and 0.1

). The results were means of three replicates.

Fig. 4.2 Reduction of L. monocytogenes Scott A (105 CFU/ml) by lysozymecarrying immunonanoparticles covalently bound with 40 µg/ml (
µg/ml (
(

) and 0.04 µg/ml (

), immunonanoparticles (

); 4 µg/ml (

); 0.4

) anti-L. monocytogenes, lysozyme solution (500 µg/ml)
) and 0.1 peptone control (

). The results were means

of three replicates.
Fig. 4.3 Reduction of L. monocytogenes Scott A (107 CFU/ml) by lysozymecarrying immunonanoparticles (

), lysozyme-carrying nanoparticles (

), lysozyme

solution (50 µg/ml) ( ), lysozyme solution (500 µg/ml) ( ), immunonanoparticles (

),

nanoparticles ( ) and 0.1 peptone control ( )over 6 hours. The results were means of
three replicates.
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Table 4.1: Antibacterial activity of lysozyme-carrying immunonanoparticles coated with
5 mg/ml lysozyme for various hours.
L. monocytogenes counts (log10 CFU/ml)

Treatments*
0h

0.1 h

3h

6h

0.1% peptone control

5.13 ± 0.04 A**

5.12 ± 0.05 A

6.09 ± 0.18 A

6.29 ± 0.06 A

INPs

5.13 ± 0.04 A

5.18 ± 0.09 A

4.85 ± 0.35 B

4.97 ± 0.36 B

Lysozyme (500 µg/ml)

5.13 ± 0.04 A

4.58 ± 0.18 B

2.62 ± 0.07 C

2.33 ± 0.14 C

L-INPs (2 h)

5.13 ± 0.04 A

3.28 ± 0.07 CD

1.90 ± 0.31 D

<1D

L-INPs (4 h)

5.13 ± 0.04 A

3.17 ± 0.05 E

1.40 ± 0.38 E

<1D

L-INPs (6 h)

5.13 ± 0.04 A

3.23 ± 0.06 DE

<1F

<1D

L-INPs (12 h)

5.13 ± 0.04 A

3.30 ± 0.05 C

<1F

<1D

L-INPs (20 h)

5.13 ± 0.04 A

3.31 ± 0.06 C

<1F

<1D

* INPs = Immunonanoparticles; L-INPs (2 h), L-INPs (4 h), L-INPs (6 h), L-INPs (12 h), L-INPs (20 h)
refer to lysozyme-carrying immunonanoparticles coated with lysozyme (5 mg/ml) for 2, 4, 6, 12 and 20
h, respectively.
**Mean ± standard deviation (n=3); Means within the same column with the same capital letter are not
significantly (P > 0.05) different.
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Table 4.2: Antibacterial activity of lysozyme-carrying immunonanoparticles coated with
various concentrations of anti-L. monocytogenes.
L. monocytogenes counts (log10 CFU/ml)
Treatments*
0h

0.1 h

3h

5h

0.1% peptone control

5.17 ± 0.09 A**

5.17 ± 0.08 A

6.04 ± 0.27 A

6.16 ± 0.10 A

INPs

5.17 ± 0.09 A

5.07 ± 0.08 A

4.82 ± 0.30 B

4.77 ± 0.33 B

Lysozyme (500 µg/ml)

5.17 ± 0.09 A

3.87 ± 0.13 B

2.52 ± 0.14 C

2.25 ± 0.12 C

L-INPs (0.04 µg/ml)

5.17 ± 0.09 A

3.26 ± 0.09 D

<1D

<1D

L-INPs (0.4 µg/ml)

5.17 ± 0.09 A

3.17 ± 0.06 D

<1D

<1D

L-INPs (4 µg/ml)

5.17 ± 0.09 A

3.21 ± 0.06 D

<1D

<1D

L-INPs (40 µg/ml)

5.17 ± 0.09 A

3.65 ± 0.42 C

<1D

<1D

*INPs= Immunonanoparticles; L-INPs (40 µg/ml), L-INPs (4 µg/ml), L-INPs (0.4 µg/ml), L-INPs (0.04
µg/ml) refer to lysozyme-carrying immunonanoparticles coated with 40, 4, 0.4 and 0.04 µg/ml anti-L.
monocytogenes, respectively.
**Mean ± standard deviation (n=3); Means within the same column with the same capital letter are not
significantly (P > 0.05) different.

134
Table 4.3: Antibacterial activity of lysozyme-carrying immunonanoparticles and
lysozyme-carrying nanoparticles.
L. monocytogenes counts log10 CFU/ml)
Treatments

0h

0.1 h

1.5 h

3h

4.5 h

6h

0.1%
peptone
control

7.15 ± 0.06 A a

7.16 ± 0.05 A

7.66 ± 0.16 A

7.88 ± 0.48 A

8.14 ± 0.10 A

8.18 ± 0.10 A

b

7.15 ± 0.06 A

7.11 ± 0.07 AB

7.13 ± 0.07 B

7.10 ± 0.13 B

6.93 ± 0.08 B

6.89 ± 0.07 B

7.15 ± 0.06 A

7.06 ± 0.07 B

6.98 ± 0.07 C

6.78 ± 0.39 C

6.82 ± 0.12 B

6.80 ± 0.11 B

7.15 ± 0.06 A

7.06 ± 0.06 B

6.73 ± 0.21 D

6.62 ± 0.17 C

6.31 ± 0.06 C

5.92 ± 0.23 C

7.15 ± 0.06 A

7.04 ± 0.12 B

6.68 ± 0.11 D

5.89 ± 0.10 D

5.07 ± 0.11 D

4.65 ± 0.21 D

7.15 ± 0.06 A

6.59 ± 0.24 C

6.48 ± 0.16 E

5.79 ± 0.30 D

4.97 ± 0.43 D

4.57 ± 0.38 D

7.15 ± 0.06 A

6.20 ± 0.10 D

5.91 ± 0.26 F

5.28 ± 0.20 E

4.05 ± 0.36 E

3.66 ± 0.30 E

NP

c

INPs

Lysozyme
(50 µg/ml)
Lysozyme
(500 µg/ml)
d

L-NPs

e

L-INPs

Mean ± standard deviation (n=3); Means within the same column with the same capital letter are not
significantly (P > 0.05) different;
b
NPs= Nanoparticles;
c
INPs= Immunonanoparticles coated with 0.04 µg/ml anti-L. monocytogenes;
d
L-NPs=Lysozyme-carrying nanoparticles with a final lysozyme concentration of 37 µg/ml;
e
L-INPs= Lysozyme-carrying immunonanoparticles coated with 0.04 µg/ml anti-L. monocytogenes and
with a final lysozyme concentration of 37 µg/ml.
a
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Lysozyme-carrying
immunonanoparticles (20 h)
Lysozyme-carrying
immunonanoparticles (12 h)
Lysozyme-carrying
immunonanoparticles (6 h)
Lysozyme-carrying
immunonanoparticles (4 h)
Lysozyme-carrying
immunonanoparticles (2 h)
Lysozyme (500 µg/ml)
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CHAPTER FIVE
CONCLUSIONS
In this study, immunonanoparticle- and fluorescent immunonanoparticle-based
immunoassays for sensitive detection of L. monocytogenes in biofilms were developed.
The use of immunonanoparticles achieved significant signal amplification for detecting
low-abundance targets in two-species biofilms that were otherwise undetectable with the
existing conventional immunoassay. The high resolution of this immunonanoparticlebased immunoassay in combination with CLSM could provid a powerful tool for
analyzing L. monocytogenes in different depths of a biofilm.
To our knowledge, this is the first report of combining immuno-magneticnanoparticle (IMNP) -based IMS with RT-PCR for a quantitative detection of L.
monocytogenes in artificially contaminated milk. IMNP-based IMS may serve as an
alternative IMS platform due to the superiority over microbead-based techniques in
capturing cells from milk system and providing DNA with less inhibitors for RT-PCR.
IMNP-based IMS combined with RT-PCR could be a promising method for rapid, ca. 6 h
of analysis time, and quantitative detection of L. monocytogenes from dairy products.
Enhanced

antibacterial

activity

was

achieved

by

lysozyme-carrying

immunonanoparticles due to the synergistic effect of using nanoparticles, anti-L.
monocytogenes and lysozyme. The development of immunonanoparticles-mediated novel
antimicrobial delivery strategy has some potential for targeted-pathogen reductions in
food or animal applications.
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In conclusion, our results demonstrated that nanotechnology could significantly
improve the current pathogen detection methods and enhance the antimicrobial activities
of existing inactivation methods.

